Advanced Practice Registered Nurses (APRN)

Discover the role of Advanced Practice Registered Nurses (APRN): highly skilled healthcare professionals providing specialized care and improving patient outcomes.

July 16, 2026

Clinical Application: Weight Management for Success

Find out how weight management techniques in a clinical application can support your journey towards a healthier weight.

Abstract: A Modern, Integrative Approach to Obesity Management

Obesity is a chronic, relapsing, and multifactorial disease that affects a staggering number of individuals worldwide. This educational post delves into the complexities of obesity, moving beyond outdated notions of willpower to explore its deep-seated neurobehavioral, metabolic, and genetic roots. We will examine the latest findings on the pharmacology of weight management, exploring how modern, evidence-based medications such as GLP-1 receptor agonists, GIP/GLP-1 therapies, naltrexone-bupropion, and others can serve as powerful tools in a comprehensive treatment plan. This discussion will highlight the critical need to combat weight bias in healthcare, which significantly hinders patient outcomes. Furthermore, we will explore how an integrative care model that combines advanced chiropractic techniques with internal medicine, functional medicine, and personalized rehabilitation provides a holistic and effective pathway for patients on their journey toward sustainable health. At our clinic, this collaborative approach is championed by Mr. Maria Guadalupe Cardenas, MD, and me, ensuring our patients receive comprehensive, multidisciplinary care.

Our Collaborative and Integrative Care Model in El Paso

At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas, we have cultivated a unique and powerful multidisciplinary environment designed to address complex health issues, such as obesity, from multiple angles. I am Dr. Alex Jimenez, and my expertise in chiropractic care, functional medicine, and Family Nurse Practitioner practice is complemented by the invaluable medical oversight of Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine and serves as our Medical Director and Collaborative Physician. With over 40 years of experience as an internist (NPI #1164426749, Texas MD License #J2933), she provides the essential medical framework for our integrative protocols.

This collaborative setup allows us to blend different disciplines for a truly holistic patient experience seamlessly:

Medical Oversight (Dr. Cardenas): Dr. Cardenas provides crucial medical direction, overseeing diagnoses and medication management, and ensuring that all treatments align with established medical safety and efficacy standards. Her role is vital, especially when considering pharmacotherapy for obesity and its related comorbidities such as hypertension, type 2 diabetes, and cardiovascular risk.
Chiropractic and Functional Medicine (Dr. Jimenez): My role involves focusing on the biomechanical and functional aspects of health. Through advanced chiropractic adjustments, we address musculoskeletal issues such as osteoarthritis, which is often exacerbated by excess weight. Using a functional medicine lens, we investigate the root causes of metabolic dysfunction, from gut health to hormonal imbalances, creating personalized nutritional and lifestyle strategies.
Integrated Services: Our team works cohesively to offer a spectrum of care that includes personal injury rehabilitation, physical therapy, and nutritional counseling. This allows us to create a unified treatment plan in which a patient can receive a chiropractic adjustment to alleviate back pain, consult with a provider on evidence-based weight-management medications under medical supervision, and receive a personalized nutrition plan, all within one coordinated system.

This team-based approach ensures that we treat the whole person, not just the symptoms, embodying the principles of modern, patient-centered integrative care. Patients are not isolated body parts; a patient with obesity, diabetes, back pain, and depression needs a coordinated strategy that respects the whole person.

Deconstructing Obesity: A Chronic and Complex Disease

We must begin by framing obesity correctly. It is not a simple matter of choice or a lack of discipline. Obesity is a chronic, progressive, relapsing, and treatable disease. This perspective is fundamental to how we approach patient care. When patients stop their anti-obesity medications, the weight often returns. This is no different than when a patient stops their antihypertensive medication, and their blood pressure rises, or when they stop chemotherapy and a malignancy returns. The condition relapses because it is chronic and deeply embedded in our physiology.

Obesity is profoundly multifactorial. It involves intricate neurobehavioral, neuroendocrine, and metabolic components. The accumulation of excess body fat promotes adipose tissue dysfunction, which is a key driver of the chronic inflammation and metabolic chaos associated with the disease. Obesity affects the body through several overlapping mechanisms:

Insulin resistance
Chronic low-grade inflammation
Leptin resistance
Altered appetite regulation
Reward pathway dysregulation
Mitochondrial dysfunction
Reduced skeletal muscle metabolic flexibility
Gut-brain signaling changes
Sleep disruption and cortisol imbalance
Mechanical overload on the spine, hips, knees, and feet

The consequences are far-reaching, impacting every system of the body:

Metabolic: Type 2 diabetes, dyslipidemia, hypertension.
Biomechanical: Osteoarthritis, back pain, incontinence.
Psychosocial: Depression, anxiety, social stigma, and discrimination.

In the United States, the statistics are sobering. 41.9% of the adult population meets the criteria for obesity (BMI ≥ 30), and a startling 9.2% have severe obesity (BMI ≥ 40). These numbers underscore the urgency of developing effective, accessible, and compassionate treatment strategies.

The Social and Environmental Drivers of Obesity

When we consider the roots of this epidemic, we must look beyond the individual to the broader environment. I often refer to the “social determinants of obesity” because factors like socioeconomic status, education, and environment play such a powerful role.

Economic Instability: For centuries, poverty was associated with being underweight. Today, the opposite is often true. In many impoverished areas, access to fresh, nutrient-dense food is limited, while calorie-dense, processed foods are cheap and abundant. This creates an environment where metabolic disease can thrive.
Neighborhood and Built Environment: If a person lives in a neighborhood where it is unsafe to walk outside, opportunities for regular physical activity are severely limited. The lack of green spaces, sidewalks, and recreational facilities contributes directly to a sedentary lifestyle.
Genetic and Hormonal Factors: We are identifying an ever-growing list of genetic and hormonal players that regulate appetite and metabolism, including ghrelin (the “hunger hormone”), GLP-1 (a satiety hormone), and leptin (which signals fullness). Research into the gut microbiota is also revealing how the balance of our intestinal flora can profoundly influence weight.
The Modern Environment: The rise of technology has engineered physical activity out of our daily lives. From desk jobs to digital entertainment, we are more sedentary than any previous generation.

Over the last decade, virtually every major medical organization, including the American Medical Association, has officially recognized obesity as a disease. This recognition is a critical step, as it validates the patient’s struggle and opens the door for proper diagnosis, treatment, and insurance coverage.

The Overwhelming Complexity of Appetite Regulation

The regulation of our appetite is an incredibly complex symphony conducted by the brain and a host of hormones. When you look at the intricate network of signals involved, it’s easy to see how a disruption in even one pathway can lead to dysfunction. Hormones like leptin, cortisol, ghrelin, and GLP-1 are in constant communication with the brain’s appetite centers, like the hypothalamus.

For many individuals with obesity, these signaling pathways are dysregulated. They may have leptin resistance, in which the brain doesn’t receive the “I’m full” signal, or ghrelin imbalances that drive persistent hunger. It becomes incredibly difficult for someone to “overpower” these potent neuroendocrine signals through willpower alone. This physiological reality is often overlooked, leading to significant clinical inertia.

Consider this shocking statistic: of the 100 million people with obesity in the United States, less than 1% receive a prescription for an anti-obesity medication. Less than 300,000 undergo bariatric surgery, despite 9.2% of the population having severe obesity. Why is there such a massive gap between the need for treatment and the care being provided? A large part of the answer lies in bias.

Binge Eating Disorder and the Physiology of Loss of Control Eating

A key concept in obesity care is recognizing binge eating disorder (BED). Binge eating disorder is not simply eating too much. It involves eating, within a discrete period of time, an amount of food larger than most people would eat under similar circumstances, combined with a sense of loss of control during the episode.

Clinically, binge eating episodes are often associated with several features:

Eating much more rapidly than normal
Eating until uncomfortably full
Eating large amounts when not physically hungry
Eating alone because of embarrassment
Feeling disgusted, depressed, guilty, or ashamed afterward
Marked distress about binge eating
Episodes occurring at least once weekly for at least three months
Absence of compensatory behaviors, such as purging, that would suggest bulimia nervosa

In practice, patients may describe getting up at night to eat while family members are asleep, hiding food, eating in the car, or waking up the next morning feeling shame and physical discomfort. I approach these disclosures with compassion because shame worsens the cycle. Patients need an evidence-based treatment plan, not judgment.

The physiology behind binge eating disorder involves dysregulation of:

Dopamine reward pathways
Impulse control circuits
Stress-related cortisol signaling
Serotonin and norepinephrine pathways
Prefrontal cortex regulation
Gut-brain satiety signaling
Emotional regulation networks

From a clinical standpoint, binge eating disorder can drive weight gain, worsen insulin resistance, aggravate depression and anxiety, and contribute to musculoskeletal pain because additional body mass increases mechanical load across the spine and joints.

Confronting Weight Bias: The Last Socially Acceptable Discrimination

Weight bias and stigma are perhaps the greatest barriers to effective obesity care. There is a pervasive, often unconscious, belief in our society—and even within the medical community—that obesity is a character flaw, a result of laziness or a lack of willpower. This prejudice is not only hurtful but also dangerous.

Research has shown that patients who experience weight bias have increased complications and mortality, independent of their BMI. The bias itself, through the stress it causes and the lack of care it fosters, becomes a risk factor. What drives this?

Lack of Reimbursement: Historically, treatments for obesity, especially medications, have not been well-covered by insurance, discouraging providers from offering them.
Time Constraints: Meaningful lifestyle counseling takes time, a luxury many providers in a fee-for-service model do not have.
Cultural Stigma: The belief that “people should just try harder” prevents us from treating obesity with the same seriousness as other chronic diseases.

This bias manifests in shocking ways. Imagine if we told patients with schizophrenia to “just stop listening to the voices.” It sounds absurd, yet we often tell patients with obesity to “just eat less and move more,” ignoring the powerful physiological drivers of their condition. We require extensive psychological screening for bariatric surgery patients—a practice not required for equally life-altering procedures like coronary artery bypass grafts—based on the biased assumption that overeating is purely a behavioral problem.

In a landmark Harvard study on implicit bias, weight bias was the only form found to increase over time. As providers, we must be the ones to break this cycle.

Shifting the Conversation: How to Engage Patients Effectively

The first step in combating bias is to change the way we talk to our patients. We need to approach the conversation with empathy, respect, and a genuine desire to help. The 5 A’s model provides a great framework:

Ask: “Is it okay if we talk about your weight and its potential effects on your health?” This simple question asks for permission and shows respect for the patient’s autonomy.
Assess: Take a detailed history. Understand their weight journey, family history, what they’ve tried in the past, and their understanding of how weight impacts health.
Advise: Provide clear, non-judgmental advice. Explain that even a modest weight loss of 3-5% can lead to significant improvements in blood pressure, blood sugar, and cholesterol.
Agree: Work with the patient to set realistic, achievable goals. What is a goal weight they feel is sustainable?
Arrange/Assist: Connect them with the resources they need. This could be a referral to a dietitian, an exercise program, or a discussion about pharmacotherapy or surgical options.

This approach transforms the conversation from one of judgment to one of partnership. Shared decision-making improves adherence because the patient becomes an active participant rather than a passive recipient.

A Framework for Treatment: Lifestyle, Medication, and Surgery

Our treatment approach is tiered and personalized, based on BMI and the presence of comorbidities (obesity-related health conditions). Current research strongly supports the idea that obesity should be treated as a chronic disease requiring ongoing monitoring, not as a temporary problem solved by short-term dieting. The Endocrine Society, American Gastroenterological Association, and American Diabetes Association emphasize that structured lifestyle therapy, medication when appropriate, and long-term follow-up are essential for improving outcomes (Apovian et al., 2015; American Diabetes Association Professional Practice Committee, 2026; Grunvald et al., 2022).

Lifestyle Interventions (BMI ≥ 25 with comorbidities, or ≥ 30): This is the foundation for everyone. It includes healthy eating, regular physical activity, and behavioral therapy. As a chiropractor and functional medicine practitioner, I often begin here, helping patients build a sustainable foundation. We focus on anti-inflammatory food plans, stress management techniques, and personalized exercise regimens that account for any musculoskeletal limitations.
Pharmacotherapy (BMI ≥ 27 with comorbidities, or ≥ 30): Medications should be considered for patients who have not reached their goals with lifestyle changes alone. These are not “magic pills” but powerful tools to aid the biological processes of appetite and metabolism.
Bariatric Surgery (BMI ≥ 35 with comorbidities, or ≥ 40): For individuals with severe obesity, surgery remains the most effective long-term treatment for significant weight loss and remission of comorbidities. It is a vital option that is tragically underutilized. A shocking 71% of providers never discuss surgical options with eligible patients.

Our goal is typically a 5-10% reduction in total body weight over six months. This level of weight loss is clinically significant and can dramatically reduce health risks.

Why “First, Do No Harm” Matters in Obesity Treatment

One of the most important principles I use in integrative obesity care is “first, do no harm.” Before adding a new medication or supplement, I want to understand whether the patient is already taking medications that may be contributing to weight gain. Common obesogenic medications may include:

Antidepressants and Antipsychotics: (e.g., some SSRIs, mirtazapine, olanzapine)
Anticonvulsants/Mood Stabilizers: (e.g., valproate, gabapentin)
Antidiabetic Agents: (e.g., sulfonylureas, insulin)
Corticosteroids: (e.g., prednisone)
Certain beta-blockers
Certain antihistamines
Some hormonal therapies

Shockingly, patients with obesity are often prescribed these medications more frequently. If a patient is on one of these drugs and struggling with their weight, we collaborate with their prescribing physician to see if a weight-neutral or weight-loss-promoting alternative exists. For instance, a patient with diabetes on a sulfonylurea like glyburide might be a candidate for a GLP-1 receptor agonist or an SGLT2 inhibitor, which can aid in weight loss. This is a perfect example of how the collaboration between Dr. Cardenas and me benefits the patient, ensuring patient safety and optimized outcomes.

Modern Pharmacotherapy for Weight Management

The good news is that we now have a growing arsenal of safe and effective long-term medications for obesity. All approved medications are more effective than placebo. A 12-week trial is often sufficient to determine whether a medication is working for a patient. If a patient does not achieve at least a 5% reduction in body weight after approximately 3 months at a therapeutic dose, we reassess the plan.

Here is an overview of some key long-term options:

Phentermine/Topiramate (Qsymia): This combination drug pairs a well-known appetite suppressant (phentermine) with an anticonvulsant (topiramate) that also reduces appetite and may lower leptin levels. Because phentermine can stimulate the sympathetic nervous system, increasing heart rate and blood pressure, it requires careful dose titration and monitoring, especially in patients with cardiovascular concerns.
Naltrexone/Bupropion (Contrave): This combination works on the brain’s reward and appetite-control centers. Bupropion stimulates the POMC system to reduce appetite, while naltrexone blocks an inhibitory feedback loop, allowing the appetite-suppressing effect to persist. This may be particularly useful for patients with co-occurring depression or reward-driven eating patterns.
Orlistat: This medication works by inhibiting gastrointestinal lipases, thereby reducing the absorption of dietary fat. It is a non-stimulant option but can cause gastrointestinal side effects and may interfere with the absorption of fat-soluble vitamins (A, D, E, K), requiring monitoring.
Liraglutide (Saxenda): A daily injectable GLP-1 receptor agonist. GLP-1 is a natural gut hormone that slows stomach emptying, promotes feelings of fullness (satiety), and acts on the brain’s appetite centers. It is started at a low dose and titrated up to 3.0 mg daily to manage potential GI side effects like nausea.
Semaglutide (Wegovy): A weekly injectable GLP-1 receptor agonist. It works similarly to liraglutide but has a longer half-life, allowing for once-weekly dosing. It has demonstrated even greater weight loss in clinical trials, with an average loss of approximately 15% of body weight (Blundell et al., 2017; Wilding et al., 2021). It is important to note that semaglutide is sold as Ozempic for type 2 diabetes and Wegovy for chronic weight management; they are the same molecule but have different indications and dosing.
Tirzepatide (Zepbound): A novel weekly injectable that is a dual GIP/GLP-1 receptor agonist. By targeting two different incretin hormone pathways, it produces a powerful synergistic effect on appetite suppression and glucose control. Clinical trials have shown unprecedented levels of weight loss, with some participants achieving more than a 20% reduction in body weight (Jastreboff et al., 2022). This potent therapy may be particularly appropriate for patients with severe obesity.
Lisdexamfetamine (Vyvanse): While not approved for general obesity, this medication is FDA-approved for moderate to severe binge eating disorder (BED). Since BED is a common co-occurring condition in patients with obesity, identifying and treating it can be a critical part of the overall weight management strategy. It works on dopamine and norepinephrine pathways to improve impulse control (McElroy et al., 2015).

Emerging Obesity Medications and Future Directions

The obesity medicine pipeline is advancing quickly. Researchers are studying therapies that may produce even more substantial weight loss while improving metabolic markers. Emerging therapies include:

Retatrutide: A triple agonist targeting GLP-1, GIP, and glucagon receptors, which has shown very large weight reduction percentages in trials (Jastreboff et al., 2023).
Oral GLP-1 agonists: Medications like orforglipron and danuglipron are being developed to provide an oral alternative to injections.
Combination therapies: CagriSema, a combination of cagrilintide and semaglutide, is being studied for its synergistic effects on appetite and metabolism.

Discovering the Benefits of Chiropractic Care- Video

The Role of Integrative Chiropractic Care in Weight Management

So, where does integrative chiropractic care fit into this modern, medical approach? It is a crucial component of our holistic model, addressing the biomechanical consequences of excess weight and enhancing the body’s ability to heal and adapt.

Addressing Biomechanical Pain: Excess weight places tremendous stress on the musculoskeletal system, leading to conditions like osteoarthritis, degenerative disc disease, and chronic back and joint pain. In my clinical observations, I frequently see patients whose weight-related concerns overlap with low back pain, sciatica, and knee pain. This pain creates a vicious cycle: it hurts to move, so the person becomes more sedentary, which can lead to further weight gain. Through precise chiropractic adjustments, spinal decompression, and soft tissue therapies, we can alleviate pain, improve joint function, and restore mobility. This enables patients to engage in the physical activity essential for weight loss.
Improving Neurological Function: The spine houses the central nervous system, which is the master controller of all bodily functions, including metabolism and hormonal regulation. By correcting spinal misalignments (subluxations), we can reduce interference in the nervous system, potentially improving the body’s ability to self-regulate and heal.
Functional Medicine and Lifestyle Coaching: As a practitioner certified in functional medicine, I look beyond the symptoms to find the underlying root causes of dysfunction. We may use advanced testing to assess gut health, hormonal imbalances, or nutrient deficiencies that contribute to weight gain. Based on these findings, we develop highly personalized nutrition plans, stress-reduction protocols, and targeted supplement recommendations to optimize metabolic function from the inside out.
Rehabilitation and Muscle Preservation: A major concern with weight loss, particularly rapid loss, is the loss of lean muscle mass. Muscle is critical for resting metabolic rate, glucose disposal, and long-term weight maintenance. My clinical approach, as reflected on my professional platforms like ChiroMed and my LinkedIn profile, emphasizes a rehabilitation-focused plan that includes progressive resistance training, core stabilization, and balance work to preserve this metabolically active tissue. Movement is metabolic medicine.

By integrating these approaches under the medical direction of Dr. Cardenas, we ensure that the patient is supported on every level—structurally, neurologically, metabolically, and medically.

Final Clinical Takeaway

If there is one concept I want patients and clinicians to remember from this post, it is this: obesity care must be individualized, medically safe, and integrated. Before adding a medication, we must ask whether current medications are worsening weight gain. Before recommending exercise, we must ask whether pain, injury, or joint dysfunction is limiting movement. Before assuming noncompliance, we must ask whether binge eating disorder, depression, anxiety, or sleep apnea are present.

With the collaborative oversight of Dr. Maria Guadalupe Cardenas, MD, and the integrative chiropractic, functional medicine, and rehabilitation services I provide, our El Paso practice model is designed to evaluate the whole patient. Modern obesity medicine is no longer about simply telling people to eat less and move more. It is about understanding physiology, reducing harm, improving function, supporting the nervous and musculoskeletal systems, and applying evidence-based tools with compassion and precision. This is the future of effective and compassionate obesity care.

References

American Diabetes Association Professional Practice Committee. (2026). Standards of Care in Diabetes 2026. Diabetes Care.
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015). Pharmacological management of obesity: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 100(2), 342–362. https://doi.org/10.1210/jc.2014-3415
Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J. (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity & Metabolism, 19(9), 1242–1251.
Grunvald, E., Shah, R., Hernaez, R., Chandar, A. K., Pickett-Blakely, O., Teigen, L. M., Yanovski, S. Z., & Singh, S. (2022). AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology, 163(5), 1198–1225. https://doi.org/10.1053/j.gastro.2022.08.045
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine, 387(3), 205–216.
Jastreboff, A. M., Kaplan, L. M., Frías, J. P., Wu, Q., Du, Y., Gurbuz, S., Coskun, T., Haupt, A., Milicevic, Z., Hartman, M. L., & Retatrutide Phase 2 Obesity Trial Investigators. (2023). Triple-hormone-receptor agonist retatrutide for obesity: A phase 2 trial. The New England Journal of Medicine, 389(6), 514–526. https://doi.org/10.1056/NEJMoa2301972
McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., Wang, J., Whitaker, T., Jonas, J., & Gasior, M. (2015). Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder. JAMA Psychiatry, 72(3), 235–246. https://doi.org/10.1001/jamapsychiatry.2014.2162
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002.

SEO Tags: Obesity Management, Integrative Care, Chiropractic, Functional Medicine, Weight Loss Medication, Semaglutide, Tirzepatide, Weight Bias, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas MD, El Paso, TX, Chronic Disease, Pharmacotherapy, Lifestyle Intervention, Adipose Tissue Dysfunction, Appetite Regulation, GLP-1 Agonists, Binge Eating Disorder, Lisdexamfetamine, Collaborative Healthcare, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, metabolic health, personal injury rehabilitation, chiropractic weight loss support, prediabetes, type 2 diabetes, obesity treatment, musculoskeletal pain, rehabilitation, internal medicine collaborative care, El Paso Texas healthcare

July 16, 2026

Regenerative Therapies for Wellness, Exercise, and Fitness

Pain and injuries can make exercise feel difficult or unsafe. A painful knee may change the way you walk. A shoulder injury may prevent you from lifting weights. An irritated spinal nerve may cause pain, numbness, tingling, or weakness that travels into an arm or leg.

At ChiroMed in El Paso, Texas, recovery is viewed as more than simply lowering pain. The goal is to understand why the pain is happening, support injured tissues, restore healthy movement, and help the patient return to exercise, work, sports, and daily activities safely.

Regenerative therapies such as platelet-rich plasma, platelet-free or platelet-poor plasma, and microfragmented adipose tissue may support the body’s natural repair process in carefully selected patients. Epidural spinal injections may help calm inflammation around irritated spinal nerves. IV infusion nutrient therapy may support hydration and correct certain nutritional deficiencies when medically appropriate.

These treatments may work best when combined with chiropractic care, functional medicine, rehabilitation, and tailored exercise. This team-based approach creates an environment where biological repair, structural alignment, cellular nutrition, and physical conditioning work together.

Building a Better Environment for Recovery

An injury can involve several problems at the same time.

A joint may be inflamed. A ligament may be weak. A spinal nerve may be irritated. Nearby muscles may tighten to protect the area. The patient may then stop moving normally because of pain.

Simply covering the pain may not correct these problems.

An integrative recovery plan may address:

Tissue irritation and inflammation
Joint stiffness or poor alignment
Weak or unbalanced muscles
Spinal nerve irritation
Poor posture or movement habits
Dehydration or nutritional deficiencies
Reduced strength and physical endurance

At ChiroMed, these factors may be evaluated together rather than treated as unrelated conditions.

The “Seed and Soil” Model of Healing

The “seed and soil” model is a simple way to explain integrative recovery.

Regenerative therapies and epidural spinal injections can be viewed as planting the “seed.” They may support the local healing environment or reduce inflammation around an irritated nerve.

Chiropractic care, functional rehabilitation, nutrition, and exercise prepare the “soil.” These treatments help improve joint motion, posture, muscle control, stability, and physical strength.

A seed may not grow well in unhealthy soil. In the same way, a regenerative procedure may have limited value if the patient continues to move poorly, overloads the injured area, or returns to strenuous exercise too quickly.

The ChiroMed recovery model may include:

Reducing pain and inflammation
Protecting the injured tissue
Improving joint and spinal motion
Supporting tissue repair
Rebuilding muscle strength
Correcting harmful movement patterns
Returning gradually to exercise and fitness

This approach does not promise an instant cure. It creates a more organized path toward recovery.

How Platelet-Rich Plasma May Support Healing

Platelet-rich plasma, commonly called PRP, is prepared from the patient’s own blood.

A small blood sample is collected and placed in a centrifuge. The centrifuge separates the blood into different parts. The platelets and plasma are then concentrated and prepared for injection into a selected joint, tendon, ligament, or muscle.

Platelets contain growth factors and signaling proteins that are involved in the body’s natural healing response. PRP may help create a biological environment that supports tissue recovery.

PRP is sometimes considered for conditions such as:

Tendon injuries
Ligament injuries
Knee osteoarthritis
Muscle injuries
Joint irritation
Certain sports injuries

Research suggests that PRP may reduce pain and improve function in some musculoskeletal conditions. However, results depend on the injury, the patient’s health, the way the PRP is prepared, and the rehabilitation plan used after treatment (Thu et al., 2022).

PRP does not automatically create new tissue or cure every injury. Evidence is stronger for some conditions than for others. Patients should receive a complete evaluation before deciding whether PRP is appropriate (Hospital for Special Surgery, 2024).

After PRP, a rehabilitation plan may progress through:

Protection and gentle movement
Light muscle activation
Controlled resistance exercises
Balance and stability training
Heavier strengthening
Sport- or work-specific activities

Exercise should be increased slowly so the healing area is not overloaded.

Understanding PFP Therapy

PFP may stand for platelet-free plasma or platelet-poor plasma. The exact meaning may vary among clinics, laboratories, and treatment protocols.

These plasma products contain fewer platelets than PRP. They may still contain proteins and other biological materials that support certain treatment goals.

PFP should not be described as the same treatment as PRP. Patients should understand what type of plasma product is being used and why it was selected.

Important questions include:

Is the product platelet-free or platelet-poor?
How is it prepared?
What condition is being treated?
Is PFP being used alone or with PRP?
What research supports its use?
Who will perform the procedure?
Will ultrasound or other imaging guide the injection?

Research comparing platelet-rich and platelet-poor preparations is still developing. The best option may depend on the tissue, injury, and desired biological response (Raum et al., 2024).

How MFAT May Support Joint Recovery

Microfragmented adipose tissue, also called MFAT, is made from a small amount of the patient’s own fat tissue.

The fat is usually collected through a minor procedure and processed into smaller fragments. The prepared tissue may then be injected into a painful joint or injured soft-tissue area.

MFAT contains structural tissue, blood vessels, signaling cells, and natural biological substances. It may help create a supportive environment around an injured or arthritic joint.

MFAT may be considered for selected patients with:

Knee osteoarthritis
Joint degeneration
Persistent joint pain
Certain cartilage injuries
Chronic soft-tissue problems

PRP and MFAT are not identical. PRP uses concentrated platelets from the blood. MFAT uses processed adipose tissue with a more complex structural environment.

Early research suggests MFAT may improve pain and function in some patients with mild to moderate osteoarthritis. However, long-term research is still limited, and results are not guaranteed (Parmar et al., 2026).

The U.S. Food and Drug Administration has warned patients that many regenerative products marketed for orthopedic conditions have not been approved to treat arthritis, disc disease, back pain, or tendon injuries. Patients should be cautious of claims that promise a guaranteed “stem-cell cure” (U.S. Food and Drug Administration, 2021).

Epidural Spinal Injections for Nerve Pain

An epidural spinal injection places anti-inflammatory medicine into the epidural space near an irritated spinal nerve.

It may be considered when a patient has pain that travels from the spine into an arm or leg. This type of pain may be caused by:

A herniated disc
A bulging disc
Spinal stenosis
Sciatica
Cervical radiculopathy
Lumbar radiculopathy
Degenerative spinal changes

The goal of an epidural injection is to reduce inflammation around the nerve. The treatment does not rebuild a damaged disc or permanently correct spinal alignment.

However, reducing nerve inflammation may create a useful period in which the patient can move, sleep, walk, and participate in rehabilitation with less pain (Cleveland Clinic, 2021).

During this rehabilitation period, the patient may begin:

Gentle walking
Core-strengthening exercises
Hip and leg strengthening
Posture training
Nerve mobility exercises
Safe lifting practice
Gradual fitness activities

The epidural injection helps calm the irritated nerve. Chiropractic care and rehabilitation address movement, posture, mobility, and strength.

The Role of IV Infusion Nutrient Therapy

IV infusion therapy delivers fluids and selected nutrients directly into the bloodstream.

It may be medically appropriate for patients with dehydration, certain nutrient deficiencies, absorption problems, or other diagnosed needs.

IV therapy may include:

Saline hydration
Electrolytes
Selected vitamins
Certain minerals
Amino acids
Physician-directed medications

In wellness and fitness settings, IV therapy is often promoted for hydration and recovery. However, IV nutrient therapy should not replace drinking water, eating nutritious foods, sleeping well, or resting after physical activity.

Research does not strongly support routine high-dose vitamin infusions for healthy people who are already well hydrated and have no diagnosed deficiency (Alangari et al., 2025).

IV therapy also carries possible risks, including:

Infection
Vein irritation
Fluid overload
Kidney stress
Medication interactions
Abnormal blood pressure
Electrolyte imbalance
Heart rhythm changes

A responsible IV program should include a health screening, a clear medical reason for treatment, sterile preparation, accurate dosing, and appropriate monitoring (Mayo Clinic Press, 2024).

At ChiroMed, IV therapy may be considered as one part of a broader wellness plan rather than as a replacement for healthy daily habits.

Chiropractic Care Helps Prepare the Body

Regenerative procedures may support tissues, but the body must still move correctly.

If joints remain stiff, muscles stay weak, or poor movement habits persist, the injured area may continue to experience harmful stress.

Chiropractic and rehabilitative care may include:

Spinal adjustments
Joint mobilization
Soft-tissue therapy
Posture correction
Mobility exercises
Core strengthening
Balance training
Functional movement exercises

Clinical guidelines support exercise, education, and selected joint mobilization methods as part of conservative low back pain care (George et al., 2021).

At ChiroMed, care is tailored to the patient’s condition. Not every patient receives the same adjustment, injection, therapy, or exercise program.

Returning to Exercise Safely

Feeling less pain does not always mean an injury has fully healed.

Returning to heavy exercise too quickly may cause another injury or increase the original problem. A gradual return-to-fitness plan may move through several stages.

Stage 1: Protect and Calm the Area

The first stage may focus on controlling pain, reducing inflammation, and avoiding movements that worsen symptoms.

Stage 2: Restore Movement

The patient may begin gentle joint motion, stretching, walking, and light muscle activation.

Stage 3: Rebuild Strength

Resistance exercises may be added to improve strength, endurance, balance, and joint stability.

Stage 4: Return to Fitness

The final stage may include heavier lifting, running, sports drills, work tasks, or other goal-specific activities.

Progress should be based on movement quality and function, not only on the amount of time that has passed.

Multidisciplinary Care at ChiroMed

ChiroMed provides a multidisciplinary setting in which chiropractic care, medical oversight, functional medicine, personal injury care, and rehabilitation may work together.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, combines experience in chiropractic care, advanced practice nursing, functional medicine, and physical rehabilitation.

His clinical observations emphasize that pain and recovery may be influenced by:

Spinal and joint movement
Muscle weakness
Posture
Nutrition
Inflammation
Sleep
Stress
Metabolic health
Previous injuries

Dr. Maria Guadalupe Cardenas, MD, works with Dr. Jimenez as a Medical Director and Collaborative Physician. She is a board-certified internal medicine physician with more than 40 years of clinical experience.

Public provider listings identify Dr. Cardenas under NPI number 1164426748 and Texas medical license J2933.

This professional structure is common in integrative and injury-care clinics. A medical doctor may provide medical direction, health screening, medication review, and oversight while the chiropractor manages structural, musculoskeletal, and rehabilitation concerns.

Dr. Cardenas’s role may include:

Reviewing chronic medical conditions
Assessing procedure risks
Reviewing medications
Evaluating laboratory findings
Coordinating medical referrals
Supporting complex case management

Dr. Jimenez’s role may include:

Musculoskeletal evaluation
Chiropractic care
Functional medicine
Personal injury care
Exercise rehabilitation
Movement correction
Nutrition and wellness education

This collaboration allows patients to receive care that considers both general health and physical function.

A Complete Approach to Wellness and Fitness

PRP, PFP, MFAT, epidural spinal injections, IV nutrient therapy, chiropractic care, and rehabilitation each have different purposes.

PRP and MFAT may support the healing environment of selected joints and soft tissues. PFP may be used in certain protocols, but its exact preparation should be explained. Epidural injections may calm spinal nerve inflammation. IV therapy may support patients with real hydration or nutrient needs.

Chiropractic care and tailored exercise help prepare the “soil” by restoring motion, improving posture, and rebuilding strength.

At ChiroMed, the goal is not only to make symptoms quieter. The goal is to help patients move better, become stronger, and return to exercise and daily life with greater confidence.

Long-term recovery usually requires more than one treatment. It may involve medical care, chiropractic care, nutrition, movement, rest, and a progressive exercise plan working together.

References

Alangari, A., et al. (2025). To IV or not to IV: The science behind intravenous vitamin therapy.

Carolina Nonsurgical Orthopedics. (2026). PRP vs. MFAT cell therapy: Which regenerative treatment is right for you?.

Cleveland Clinic. (2021). Lumbar epidural steroid injections: What it is, benefits, risks, and side effects.

George, S. Z., et al. (2021). Interventions for the management of acute and chronic low back pain: Revision 2021. Journal of Orthopaedic & Sports Physical Therapy, 51(11), CPG1-CPG60.

Hospital for Special Surgery. (2024). Platelet-rich plasma injection: How it works.

Jimenez, A. (n.d.). Dr. Alexander Jimenez: Chiropractic and integrative medicine.

Jimenez, A. (n.d.). Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP.

Jimenez, A. (2026). How PRP composition influences your healing journey.

Mayo Clinic Press. (2024). IV vitamin therapy: Understanding the lack of proven benefit and potential risks.

Open Wellness PDX. (2025). What is regenerative injection therapy? A complete guide to PRP, prolotherapy, and perineural injection.

Parmar, T., et al. (2026). Microfragmented adipose tissue in orthopedic regeneration.

Raum, G., et al. (2024). Platelet-poor versus platelet-rich plasma for the treatment of muscle injury.

Thu, A. C., et al. (2022). The use of platelet-rich plasma in the management of musculoskeletal pain: A narrative review.

U.S. Food and Drug Administration. (2021). Important patient and consumer information about regenerative medicine therapies.

July 15, 2026

Integrative Accident and Work Injury Care in El Paso

An auto accident or workplace injury can affect the body in several ways at the same time. A person may experience inflammation, muscle spasms, joint stiffness, ligament damage, nerve irritation, weakness, and poor movement.

Rest may help mild soreness. However, stubborn injuries often need a more complete recovery plan.

At ChiroMed – Integrated Medicine in El Paso, care focuses on the whole injury rather than just covering up pain. An integrative wellness plan may combine chiropractic care, medical assessment, functional medicine, rehabilitation, nutrition, and advanced therapies when appropriate.

The main goals are to:

Calm pain and inflammation
Identify the injured tissues
Restore spinal and joint movement
Support natural tissue repair
Rebuild strength and stability
Help the patient return to work and daily activities
Reduce the risk of long-term pain

This layered approach gives patients a clear path from the early stages of an injury to long-term functional recovery.

Why Accident and Work Injuries Need a Complete Plan

Accidents can place great force on the spine, joints, muscles, and connective tissues.

During a car crash, the body may move forward, backward, or sideways before a person has time to react. A seat belt can save a life, but it may also place pressure across the shoulder, chest, or hip. Drivers may grip the steering wheel or brace their arms before impact, which can contribute to shoulder, elbow, wrist, or hand injuries.

Work injuries can happen during:

Repeated lifting
Pushing or pulling
Slips and falls
Awkward twisting
Repetitive arm movements
Long periods of sitting
Heavy labor
Machinery accidents
Poor workstation setup

Common symptoms include neck pain, back pain, headaches, sciatica, joint stiffness, muscle spasms, numbness, tingling, weakness, and reduced range of motion.

Some symptoms begin right away. Others take several hours or days to become noticeable as swelling and muscle guarding increase. For this reason, early evaluation can be important even when the patient believes the injury is minor (El Paso Chiropractor Blog, 2026a, 2026b).

Phase One: Identify the Injury and Reduce Inflammation

The first stage of care begins with a complete evaluation.

The provider asks how the injury happened, which body parts were affected, when symptoms began, and which activities make the pain better or worse. The examination may include posture testing, range-of-motion measurements, orthopedic tests, neurological screening, muscle strength testing, and movement analysis.

Imaging or referral may be needed when the examination suggests:

A fracture
A major ligament tear
Severe joint instability
A traumatic brain injury
Spinal cord involvement
Progressive muscle weakness
Loss of bowel or bladder control
Infection
A medical emergency

The early treatment plan is usually gentle. The goal is not to force a painful area to move. Instead, care may focus on reducing irritation, protecting injured tissues, controlling muscle spasms, and maintaining safe movement.

Early treatment may include:

Gentle joint movement
Soft-tissue therapy
Cold or heat when appropriate
Light corrective exercises
Activity changes
Supportive taping or bracing
Nutrition and hydration guidance

A safe plan also considers the patient’s age, medical history, medications, previous injuries, job duties, and overall health.

Phase Two: Restore Spinal and Joint Mechanics

Once the patient can move more safely, treatment may begin addressing restricted joints, poor posture, and abnormal movement patterns.

Chiropractic Care

Chiropractic care focuses on how the spine, joints, muscles, and nervous system work together.

After an accident, muscle guarding may limit normal joint movement. When one area does not move properly, nearby muscles and joints often work harder to compensate for the restriction. This can create a cycle of pain, stiffness, and poor movement.

Carefully selected chiropractic adjustments and joint mobilization may help:

Restore joint movement
Reduce mechanical stress
Improve range of motion
Decrease muscle guarding
Support better posture
Make rehabilitation more comfortable

Chiropractic care does not replace emergency medicine, orthopedic care, or other medically necessary services. It is one part of a coordinated injury-recovery plan.

Research suggests that spinal manipulation may provide modest improvements in pain and function for some patients with neck or back pain. Treatment must be selected according to the patient’s examination, diagnosis, comfort, and risk factors (National Center for Complementary and Integrative Health [NCCIH], n.d.).

Spinal Decompression

Spinal decompression uses controlled traction to gently stretch the spine.

It may be considered for selected patients with:

Bulging or herniated discs
Sciatica
Disc-related neck pain
Nerve irritation
Spinal stiffness

The goal is to reduce mechanical pressure and make movement more comfortable. Decompression may also be combined with chiropractic care and corrective exercises.

It is not suitable for every patient. People with fractures, severe osteoporosis, tumors, major spinal instability, or certain medical conditions may need a different form of care.

Spinal decompression should not be presented as a stand-alone cure. Long-term improvement usually also requires stronger muscles, better movement patterns, and changes to activities that continue to place stress on the spine (Sciatica Clinic, 2026a).

Phase Three: Address Stubborn Soft-Tissue Injuries

Muscles, tendons, ligaments, cartilage, and spinal discs do not all heal at the same rate.

Some tissues have a limited blood supply. Others continue to face stress from poor posture, joint instability, repetitive work, or abnormal movement. When an injury does not improve with rest and basic conservative care, additional procedures may be discussed.

Platelet-Rich Plasma Therapy

Platelet-rich plasma, or PRP, is prepared from the patient’s own blood. A medical professional processes the blood to create a platelet-rich portion.

Platelets contain proteins and growth factors involved in the body’s normal healing response. PRP may be considered for selected tendon, ligament, muscle, or joint injuries.

PRP does not instantly rebuild damaged tissue. It is designed to support the natural repair process. Results may also depend on:

The type and severity of the injury
The patient’s health
The way the PRP is prepared
How accurately it is placed
Activity after the procedure
The rehabilitation plan
Continued mechanical stress on the area

Dr. Alexander Jimenez’s clinical observations emphasize that regenerative procedures should be combined with improved biomechanics. Treating injured tissue without correcting the movement problem that continues to stress it may limit recovery (Jimenez, 2026).

Microfragmented Adipose Tissue

Microfragmented adipose tissue, commonly called MFAT, is prepared from a small amount of the patient’s fat tissue.

The processed tissue contains structural and signaling components that may support selected orthopedic procedures. It may be considered for some joint, cartilage, or complex soft-tissue conditions.

MFAT requires a fat-harvesting procedure and is more involved than a standard blood draw. PRP and MFAT are not the same treatment.

The choice may depend on:

The injured structure
How long symptoms have been present
Imaging findings
Previous treatments
The patient’s overall health
The expected risks and benefits

No regenerative procedure is best for every patient. A qualified medical provider must first determine whether the person is a suitable candidate (Sports Medicine of the Rockies, 2026).

Patients should also be careful with clinics that promise guaranteed tissue regrowth or market unapproved products as cures. Regenerative procedures should be based on a clear diagnosis, realistic expectations, and proper medical screening.

Laser and Shockwave Therapy

Noninvasive technologies may be used to support pain relief and rehabilitation.

Therapeutic Laser

Therapeutic laser treatment uses selected wavelengths of light over the injured area. This process is often called photobiomodulation.

The therapy may influence cellular activity, local circulation, and inflammatory signals. It may be used as a supportive option for muscle pain, joint irritation, or soft-tissue injuries.

Laser treatment does not physically align the spine or replace exercise. Its role is to help reduce discomfort so the patient can participate more comfortably in movement and rehabilitation.

Shockwave Therapy

Extracorporeal shockwave therapy uses acoustic waves to stimulate targeted tissue.

It is often considered for chronic tendon and soft-tissue problems, including:

Plantar fasciitis
Tennis elbow
Achilles tendon pain
Calcific shoulder conditions
Chronic muscle or tendon pain
Areas with long-standing scar tissue

Shockwave therapy may support circulation, collagen activity, and tissue remodeling. Temporary soreness can occur after treatment.

Patients with certain bleeding risks, infections, tumors, or other medical concerns may not be suitable candidates. Screening should take place before treatment begins (Harrington, n.d.).

Phase Four: Support Healing Through Nutrition

The body needs adequate nutrients to repair injured tissues.

Protein supplies amino acids used to maintain and rebuild muscles, tendons, ligaments, and other tissues. Vitamins and minerals support energy production, nerve function, collagen formation, and immune activity.

A recovery-focused nutrition plan may include:

Adequate protein
Vegetables and fruits
Healthy fats
Whole-food carbohydrates
Enough water
Foods containing vitamin C
Foods containing magnesium and zinc
Stable meal timing
Reduced heavily processed food intake

Sleep also matters. The body performs many repair processes during sleep. Poor sleep can increase pain sensitivity, reduce energy, and make it harder to follow a rehabilitation program.

Functional medicine may help identify other issues that can slow recovery, such as poor blood sugar control, nutrient deficiencies, digestive concerns, chronic inflammation, or unhealthy lifestyle habits.

IV Nutrient Support

IV fluids or nutrients may be considered when there is a clear medical reason, such as dehydration, poor absorption, or a documented deficiency.

IV therapy sends fluids and selected nutrients directly into the bloodstream. It must be provided with proper screening, sterile technique, careful dosing, and medical oversight.

IV therapy should not replace:

Healthy food
Water
Sleep
Chiropractic care
Rehabilitation
Necessary medical treatment

It should also not be promoted as a guaranteed way to heal an injury. Evidence for routine high-dose vitamin infusions in otherwise healthy people remains limited. The treatment must match the patient’s individual medical needs (Alangari et al., 2025).

Phase Five: Rebuild Strength and Function

Pain relief is not the final step.

A patient must regain the ability to walk, bend, lift, reach, work, exercise, and safely complete daily activities. This requires functional rehabilitation.

A rehabilitation program may include:

Range-of-motion exercises
Core strengthening
Hip and leg strengthening
Shoulder stability exercises
Balance training
Posture correction
Walking or aerobic conditioning
Work-specific movements
Gradual lifting practice
Home exercises

Exercise should progress in stages. Too much activity too soon may irritate healing tissues. Too little movement for too long may lead to stiffness, weakness, and fear of movement.

Progress can be measured through:

Improved range of motion
Reduced pain
Better muscle strength
Greater walking tolerance
Improved lifting ability
Better balance
Safer work activity
Increased independence

Team-Based Injury Care at ChiroMed

ChiroMed – Integrated Medicine in El Paso uses a multidisciplinary approach to treating accident, work, and sports injuries, as well as chronic musculoskeletal conditions.

The clinic’s services may bring together:

Chiropractic care
Nurse practitioner services
Medical evaluation and oversight
Functional medicine
Rehabilitation
Nutrition counseling
Soft-tissue treatment
Spinal decompression
Therapeutic laser
Shockwave therapy
Regenerative medicine consultations
Personal injury documentation

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, leads chiropractic and integrative clinical care. His combined background in chiropractic, advanced practice nursing, functional medicine, spinal trauma, and rehabilitation allows him to view an injury from several clinical angles.

His clinical observations focus on identifying the cause of ongoing pain rather than treating only the painful area. This includes examining joint mechanics, nerve function, muscle balance, nutrition, inflammation, lifestyle, and the patient’s ability to perform normal activities.

Dr. Maria Guadalupe Cardenas, MD, is board-certified in internal medicine and brings more than 40 years of clinical experience. She serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA.

Her Texas medical license is J2933. Current public provider listings identify her NPI as 1164426748.

Dr. Cardenas provides medical direction alongside Dr. Jimenez’s chiropractic, functional medicine, personal injury, and rehabilitation services. This type of structure is common in multidisciplinary injury clinics.

The chiropractor and rehabilitation team focus on spinal mechanics, joint motion, soft-tissue function, and corrective exercises. The medical physician supports clinical oversight, complex case review, medical safety, and coordination when a patient needs services beyond conservative musculoskeletal care.

A Clearer Path From Injury to Recovery

A complete injury plan is not based on placing every patient into the same treatment program.

The right plan depends on:

How the injury happened
Which tissues were damaged
How severe the symptoms are
The patient’s overall health
Work and family responsibilities
Previous treatments
Response to care

At ChiroMed, the recovery process may move from inflammation control to structural care, tissue support, and functional rehabilitation.

Chiropractic care and decompression address mechanical stress. PRP, MFAT, laser, and shockwave therapy may support selected injuries. Nutrition and medically appropriate IV therapy support overall health. Rehabilitation helps the patient regain strength and function.

The purpose is not only to manage pain today. It is to help the patient understand the injury, correct contributing problems, support natural healing, and build a stronger foundation for the future.

To learn more about integrative accident or work injury care in El Paso, visit ChiroMed – Integrated Medicine or call 915-850-0900.

References

Alangari, A., et al. (2025). To IV or not to IV: The science behind intravenous vitamin therapy.

ChiroMed. (n.d.-a). About ChiroMed – Integrated Medicine.

ChiroMed. (n.d.-b). Integrated injury care in El Paso, Texas.

ChiroMed. (n.d.-c). Integrated medicine services in El Paso, Texas.

ChiroMed. (2026). Regenerative therapy for auto accident injury recovery.

El Paso Chiropractor Blog. (2026a). Arm and shoulder injuries after auto accidents.

El Paso Chiropractor Blog. (2026b). Speeding and aggressive driving accidents.

Harrington, P. (n.d.). Comparing Class 4 laser therapy, PEMF, and shockwave treatments in chiropractic care.

Jimenez, A. (2026). How PRP composition influences your healing journey.

National Center for Complementary and Integrative Health. (n.d.). Spinal manipulation: What you need to know.

New Regeneration Orthopedics. (2021). Chiropractors: How to integrate regenerative medicine into your practice the right way.

Sciatica Clinic. (2026). Integrated posture care combining multiple therapies.

Sports Medicine of the Rockies. (2026). Comparing PRP, BMAC, and MFAT: Choosing the right regenerative treatment.

The Neck and Back Clinics. (n.d.). What are your chiropractic treatment options after a car accident?.

July 14, 2026

GLP-1 Receptor Agonist Effects On Cardiometabolic Health

Find out how GLP-1 receptor agonists contribute to better cardiometabolic health and what it means for you.

Abstract

The intertwined relationship between type 2 diabetes, obesity, heart failure, and cardiovascular disease represents a significant clinical challenge. Over the past decade, two revolutionary drug classes, SGLT2 inhibitors and GLP-1 receptor agonists, have transformed our approach by offering profound benefits beyond glucose control. This educational post explores the latest findings from leading researchers on the physiological underpinnings connecting these conditions. We will delve into how metabolic disturbances like hyperglycemia and insulin resistance drive chronic inflammation, endothelial dysfunction, and detrimental cardiac remodeling. We will highlight the evidence from landmark trials—including DAPA-HF, EMPEROR-Preserved, SELECT, and LEADER—that have cemented these medications as cornerstones of cardiometabolic care. I will also explain how our team at Injury Medical Clinic PA, under the medical direction of our Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD, integrates these pharmacological advances with integrative chiropractic care, functional medicine, and rehabilitation to provide comprehensive, patient-centered care that addresses root causes and optimizes well-being.

Our Collaborative Approach at Injury Medical Clinic PA

Before diving into the science, I want to introduce the framework I use. At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, located in El Paso, Texas, our approach is inherently collaborative and multidisciplinary.
As the founder, I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, function within our team as both a Doctor of Chiropractic and a board-certified Family Nurse Practitioner with advanced certifications in functional and integrative medicine. This multifaceted training allows me to view patient health through a unique lens, connecting musculoskeletal integrity, nervous system function, and metabolic health. My clinical observations and published work are available at chiromed.com and my LinkedIn profile.
A cornerstone of our clinic is the medical oversight provided by our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749, Texas MD License #J2933). With over 40 years of experience as a board-certified internist, Dr. Cardenas brings an extraordinary depth of knowledge, particularly for patients managing complex, overlapping conditions like heart failure, type 2 diabetes, hypertension, chronic kidney disease (CKD), and obesity. Her long tenure in internal medicine means she has witnessed firsthand the evolution of cardiometabolic pharmacology, from older agents to today’s transformative era of SGLT2 inhibitors and GLP-1 receptor agonists.
Together, Dr. Cardenas and I lead a team that integrates:

Medical Oversight and Internal Medicine: Dr. Cardenas provides essential medical direction, overseeing complex cases and managing pharmacological interventions.
Chiropractic Care and Spinal Rehabilitation: I focus on spinal alignment, nervous system function, and musculoskeletal health to reduce pain, improve mobility, and enhance the body’s innate healing capacity.
Functional Medicine and Lifestyle Interventions: We investigate the root causes of chronic illness through advanced diagnostics and personalized protocols.
Personal Injury Care and Musculoskeletal Rehabilitation: Our team provides specialized care for individuals recovering from accidents, with a focus on restoring function.
Nutritional Counseling and Metabolic Optimization: We create targeted dietary plans to combat inflammation and improve metabolic health.

This integrative structure is vital when addressing complex conditions like cardiometabolic syndrome. By combining these disciplines, we create personalized treatment plans that go beyond symptom management to foster true healing and resilience.

The Unseen Connection: How Diabetes Fuels Heart Failure

As a clinician with decades of experience, I’ve observed that diabetes and heart failure are far more than just concurrent diagnoses; they are deeply interconnected diseases that are, as one of my esteemed colleagues put it, “joined at the hip.” Understanding the “why” behind this connection is crucial for effective treatment. When we grasp the underlying physiology, the logic behind using specific therapies becomes crystal clear.
The journey from diabetes to heart failure is a cascade of metabolic and inflammatory events:

Hyperglycemia and Insulin Resistance: In type 2 diabetes, the body’s cells become resistant to insulin, leading to elevated blood sugar levels (hyperglycemia). This resistance isn’t just a sugar problem; it’s a systemic issue.
Hyperinsulinemia: To compensate for this resistance, the pancreas works overtime, pumping out increasing amounts of insulin. This state of high insulin, or hyperinsulinemia, is a powerful, independent driver of inflammation.
Chronic Inflammation and Endothelial Dysfunction: This inflammatory milieu, often compounded by obesity-related inflammation from excess adipose (fat) tissue, damages the delicate inner lining of our blood vessels—the endothelium. This endothelial dysfunction is the first step toward atherosclerosis, where plaques begin to form in the arteries.
Cardiac Remodeling and Fibrosis: Simultaneously, the heart muscle itself is under attack. The combination of inflammation, metabolic stress, and activation of the Renin-Angiotensin-Aldosterone System (RAAS)—a hormonal system that regulates blood pressure and fluid balance—leads to adverse changes. The heart muscle can thicken (left ventricular hypertrophy, or LVH) and develop scar tissue (fibrosis), making it stiffer and less efficient.

This entire process can lead to what is known as diabetic cardiomyopathy, a form of heart failure that can develop even without the classic clogged arteries of coronary artery disease. It’s a direct consequence of the metabolic chaos that diabetes creates. My clinical observations at Injury Medical Clinic align with this research; we frequently see patients whose musculoskeletal and nerve issues are exacerbated by underlying systemic inflammation driven by metabolic disorders like diabetes (Jimenez, 2024).

Understanding the Two Faces of Heart Failure

Heart failure is not a one-size-fits-all condition. It’s broadly classified based on the heart’s pumping capacity, measured by the ejection fraction (EF). This distinction is vital because the underlying mechanisms and treatment approaches differ significantly.

Heart Failure with Preserved Ejection Fraction (HFpEF)

What it is: In HFpEF, the ejection fraction is normal or near-normal (50% or greater). The problem isn’t the squeeze; it’s the relaxation. The heart muscle, particularly the left ventricle, becomes stiff and thickened (concentric remodeling), impairing its ability to fill with blood properly during diastole.
Who it affects: HFpEF is more common in older adults, women, and individuals with obesity, diabetes, and hypertension.
The “Why”: This condition is primarily driven by systemic inflammation, endothelial dysfunction, and microvascular damage in the heart and kidneys.
Treatment Focus: The goals are to manage congestion (fluid buildup), control risk factors such as blood pressure and diabetes, and use therapies such as SGLT2 inhibitors to help reduce the burden of cardiac remodeling.

Heart Failure with Reduced Ejection Fraction (HFrEF)

What it is: In HFrEF, the ejection fraction is reduced (less than 40%). The heart muscle is weakened and often enlarged (eccentric remodeling and ventricular dilation), impairing its ability to contract and pump blood effectively.
Who it affects: HFrEF is more commonly seen in men and is often the result of ischemic heart disease (e.g., a prior heart attack). However, patients with HFpEF can progress to HFrEF over time.
The “Why”: This condition is driven primarily by overactivation of neurohormonal systems, including the RAAS and the sympathetic nervous system (the “fight or flight” response).
Treatment Focus: The cornerstone of HFrEF management is quadruple medical therapy, which includes an ARNI (angiotensin receptor-neprilysin inhibitor), a beta-blocker, an MRA (mineralocorticoid receptor antagonist), and an SGLT2 inhibitor. This combination is designed to block the harmful neurohormonal pathways and improve cardiac function.

Optimizing Your Wellness- Video

The Four Pillars of Modern Diabetes and Cardiovascular Care

The American Diabetes Association has outlined a strategy that mirrors the “pillar” approach used in heart failure management. To effectively reduce the cardiovascular risks associated with diabetes, we must focus on four key areas:

Glycemic Management: Controlling blood sugar is fundamental.
Blood Pressure Management: Protecting the blood vessels from the damaging effects of high pressure.
Lipid Management: Managing cholesterol and triglycerides to prevent plaque buildup.
Using Cardiorenal Protective Agents: This is where the game has truly changed. We now prioritize medications that do more than just lower blood sugar; we use agents with proven benefits for the heart and kidneys.

The two classes of medications at the forefront of this revolution are SGLT2 inhibitors and GLP-1 receptor agonists. These drugs have become indispensable tools, offering powerful benefits that address the core physiological problems linking diabetes, heart failure, and kidney disease.

The Revolutionary Role of SGLT2 Inhibitors

When Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors first appeared around 2014, their mechanism seemed straightforward: block the reabsorption of glucose in the kidneys, causing excess sugar to be excreted in the urine. It was an interesting way to lower blood sugar, but no one could have predicted the profound impact this drug class would have on cardiovascular and renal medicine. Today, SGLT2 inhibitors are a core pillar of heart failure therapy for patients with or without diabetes. Major clinical trials have provided undeniable evidence of their efficacy.

Landmark Trials: The Evidence Speaks for Itself

The data supporting SGLT2 inhibitors is overwhelming, stemming from large, well-designed clinical trials that have reshaped treatment guidelines.

EMPEROR-Reduced & DAPA-HF: These trials, which studied empagliflozin and dapagliflozin, respectively, were groundbreaking. They showed that in patients with HFrEF, these drugs reduced the risk of cardiovascular death and hospitalization for heart failure by approximately 25-26%. These trials cemented SGLT2 inhibitors as a mainstay of HFrEF treatment, demonstrating robust benefits in the outpatient setting that prompted further investigation (Packer et al., 2020; McMurray et al., 2019).
EMPULSE: This trial translated the benefits seen in outpatients directly to hospitalized patients with acute heart failure. This is clinically significant because it shows these are not drugs we must wait to initiate. They can be safely used across all NYHA functional classes and in both compensated and decompensated states at a simple, uniform dose (e.g., Dapagliflozin 10 mg daily).
EMPEROR-Preserved: This was a monumental moment for cardiology. For the first time, a medication—empagliflozin—demonstrated a clear benefit in patients with HFpEF, a condition that had been notoriously difficult to treat. It delivered meaningful reductions in both CV death and heart failure hospitalization, with a 27% relative risk reduction in hospitalizations regardless of diabetes status (Anker et al., 2021). This is transformative for the older, obese patient population I frequently see at Injury Medical Clinic PA.
EMPA-KIDNEY & CREDENCE: These trials shifted focus to the kidneys. They showed that SGLT2 inhibitors (empagliflozin and canagliflozin) significantly slowed the progression of chronic kidney disease (CKD) and reduced the risk of kidney failure by 28-30% (The EMPA-KIDNEY Collaborative Group, 2022; Perkovic et al., 2019). This is critical because kidney function is a powerful predictor of survival in patients with heart failure and diabetes.

These results confirm that the benefits are a class effect, meaning the protective mechanisms are shared across the different drugs in this category.

How SGLT2 Inhibitors Protect the Heart and Kidneys

The power of SGLT2 inhibitors lies in their multifaceted mechanism of action, which goes far beyond simple glucose excretion.

Improved Cardiac Fuel Efficiency: This is one of the most fascinating aspects. A failing, metabolically stressed heart is inefficient at using glucose for fuel. However, it remains very good at using ketones as an energy source. SGLT2 inhibitors induce a mild state of ketosis, providing the sick heart with its preferred, more efficient fuel. It’s like giving a struggling engine a supply of premium fuel, improving ATP production and optimizing the cellular Krebs cycle.
Hemodynamic and Renal Benefits:
- By promoting the excretion of sodium and water (natriuresis), these drugs act as a gentle diuretic, reducing circulating blood volume (preload) and the overall hemodynamic burden on the heart.
- They decrease the pressure inside the glomeruli (the kidney’s filtering units), which reduces stress on the kidneys and slows the progression of CKD. A common fear is the initial dip in eGFR when starting the drug, but this is an expected hemodynamic effect, not a sign of kidney injury. It signals the drug is working.
Reduced Inflammation and Fibrosis: SGLT2 inhibitors have been shown to reduce myocardial inflammation and fibrosis (scarring). They also help reduce epicardial adipose tissue—the inflammatory layer of fat that sits directly on the heart—which is a major contributor to cardiac dysfunction in obesity and diabetes.
Atherosclerotic Plaque Stabilization: By reducing systemic inflammation, oxidative stress, and endothelial dysfunction, SGLT2 inhibitors help stabilize vulnerable plaques, which, in synergy with statins, can provide risk reduction exceeding that of statins alone.

GLP-1 Receptor Agonists From Diabetes Drugs to Cardiovascular Powerhouses

While SGLT2 inhibitors have cornered the market on heart failure, GLP-1 receptor agonists have emerged as powerhouses for reducing atherosclerotic cardiovascular events and promoting significant weight loss.

How GLP-1 Receptor Agonists Work

GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists), such as semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide (Victoza), mimic the action of the endogenous incretin hormone GLP-1. Their key mechanisms include:

Delayed Gastric Emptying: This slows nutrient absorption, blunting postprandial glucose excursions and promoting satiety.
Central Appetite Suppression: They act on GLP-1 receptors in the central nervous system to directly reduce appetite signals, leading to an average weight loss of 13-16% of body weight in clinical trials.
Reduced Systemic Inflammation: They lower inflammatory cytokines, such as IL-6 and TNF-alpha, derived from visceral fat, a metabolically active inflammatory organ.
Atherosclerotic Plaque Stabilization: By reducing macrophage infiltration, foam cell formation, and endothelial activation, GLP-1 receptor agonists slow plaque growth and improve its stability, lowering the risk of acute coronary events.

Critically, GLP-1 receptor agonists lower glucose only when it is elevated and a patient is eating. They have a minimal risk of causing hypoglycemia, making them exceptionally safe for long-term outpatient use.

The FDA-Mandated Outcomes Trials: A Turning Point

Following safety concerns with older antidiabetic drugs, the FDA mandated large cardiovascular outcomes trials for all new glycemic agents starting around 2008. These trials unexpectedly revealed significant cardiovascular benefits for the GLP-1 class.

Trial	Drug	Key Finding
LEADER (2016)	Liraglutide (Victoza)	13% reduction in MACE risk in over 9,300 patients (Marso et al., 2016).
SUSTAIN-6	Semaglutide (Ozempic)	26% MACE risk reduction.
REWIND	Dulaglutide (Trulicity)	12% MACE risk reduction.
PIONEER	Oral semaglutide (Rybelsus)	21% MACE risk reduction.
SELECT	Semaglutide 2.4 mg (Wegovy)	20% CV risk reduction in non-diabetic obese patients (Lincoff et al., 2023).

MACE (Major Adverse Cardiovascular Events) is a composite score typically including cardiovascular death, non-fatal myocardial infarction (MI), and non-fatal stroke. The SELECT trial was particularly groundbreaking, proving that the cardiovascular benefits of semaglutide extend to obese patients without diabetes, dramatically expanding the eligible population for this therapy. Furthermore, the STEP Heart Failure trial (2023) showed that in obese HFpEF patients without diabetes, semaglutide significantly improved quality of life, exercise function, and heart failure symptoms, underscoring the benefits of weight loss in this population.

The ADA Algorithm Drug Selection Framework

The American Diabetes Association (ADA) provides clear guidelines for choosing between these two powerful drug classes:

For patients with established ASCVD (atherosclerotic cardiovascular disease): Prefer GLP-1 receptor agonists first.
For patients with heart failure or chronic kidney disease (CKD): Prefer SGLT2 inhibitors first.
For high-risk patients with overlapping conditions: Consider using both classes simultaneously, a strategy increasingly supported by insurance given the strength of the evidence.

A Clinical Case Example Transitioning Patients to Modern Therapy

To put this into practice, consider a common clinical scenario. Let’s call our patient Bob. He is a recently insured man with type 2 diabetes who suffered a myocardial infarction two months ago and was subsequently diagnosed with HFrEF. His prior regimen, based on cost, included metformin, a sulfonylurea, and a DPP-4 inhibitor. His A1C was 7.0%.
This old regimen was designed purely to lower glucose, not to reduce cardiovascular risk. This represents the paradigm shift in modern cardiometabolic medicine: we are no longer just managing blood sugar; we are managing cardiovascular survival.

Sulfonylureas: These drugs induce insulin secretion regardless of glucose levels, increasing the risk of hypoglycemia. They offer no cardiac benefit and have been associated with adverse outcomes.
DPP-4 Inhibitors: While incretins, they do not confer the direct cardiovascular, weight-loss, or anti-inflammatory benefits of GLP-1 receptor agonists. They are an inferior choice.

The rational transition plan for Bob, which Dr. Cardenas and I would implement, is:

Discontinue the sulfonylurea immediately to eliminate hypoglycemia risk.
Retain metformin, which remains a foundational agent.
Add an SGLT2 inhibitor (such as dapagliflozin or empagliflozin) for its proven benefit in HFrEF.
Replace the DPP-4 inhibitor with a GLP-1 receptor agonist to reduce ASCVD risk.
Ensure he is on all four pillars of HFrEF therapy: an ARNI, a beta-blocker, an MRA, and the SGLT2 inhibitor.

While this may seem like polypharmacy, it is evidence-based and life-saving. Each drug class targets a distinct and complementary pathway. Refusing to use them together is a disservice to the patient.

The Integrative Chiropractic and Functional Medicine Perspective

At Injury Medical Clinic, our approach, under the medical direction of Dr. Cardenas, is to build upon this powerful medical foundation. While medications address the deep cellular and hormonal imbalances, our role is to optimize the body’s overall function and resilience. Patients with cardiometabolic disease rarely suffer in isolation; they often present with chronic pain, spinal dysfunction, and sedentary behavior that worsen their condition.

How Our Integrative Care Fits In

Reducing Systemic Inflammation: The chronic inflammation driven by diabetes is a central villain. Our functional medicine protocols identify and mitigate sources of inflammation through advanced diagnostics and personalized interventions such as anti-inflammatory nutrition and gut health restoration.
Improving Biomechanics and Autonomic Function: Diabetes often leads to autonomic dysfunction. Precise chiropractic care can help restore proper spinal alignment and improve nerve function. By modulating nerve signals, particularly in the thoracic spine, where sympathetic ganglia that influence heart function are located, chiropractic care can help balance the autonomic nervous system. My clinical experience has shown that patients often report improved well-being and better symptom management after consistent care (Jimenez, 2024). This complements the work of beta-blockers, which also target sympathetic overactivity.
Enabling Physical Rehabilitation: Musculoskeletal pain is a major barrier to exercise. Chiropractic care can alleviate this pain, enabling patients to engage in structured exercise programs that improve cardiovascular fitness, enhance insulin sensitivity, and promote healthy weight.
Supporting Cellular Health: The discussion of ketones highlights the importance of cellular energy. Through functional medicine, we may recommend targeted supplementation with nutrients like Coenzyme Q10, magnesium, and B vitamins, which are essential for mitochondrial function. This nutritional support ensures the “powerhouses of the cell” have the raw materials they need to function optimally, amplifying the benefits of therapies that improve the heart’s fuel supply.

Our collaborative model ensures that these holistic therapies are safely and effectively integrated alongside the medical treatments prescribed and overseen by Dr. Cardenas. This team-based approach allows us to address the patient as a whole person—supporting their journey from every angle: cellular, structural, and systemic. By embracing these principles, we can truly change the trajectory of cardiometabolic disease and help our patients live longer, healthier lives.

References

SEO Tags: SGLT2 inhibitors heart failure, GLP-1 receptor agonists cardiovascular outcomes, type 2 diabetes, semaglutide cardiovascular benefits, dapagliflozin heart failure, empagliflozin HFpEF, MACE reduction diabetes, cardiometabolic disease treatment, integrative chiropractic care El Paso, functional medicine cardiovascular disease, Dr. Alex Jimenez DC APRN, Injury Medical Clinic PA El Paso, Dr. Maria Guadalupe Cardenas MD internal medicine, GLP-1 weight loss cardiovascular, SGLT2 inhibitors diabetes, SELECT trial semaglutide obesity, DAPA-HF trial, EMPEROR-Preserved trial, LEADER trial liraglutide, HFrEF treatment guidelines, HFpEF treatment, polypharmacy heart failure diabetes, sulfonylurea transition, DPP-4 inhibitor GLP-1 switch, Wegovy cardiovascular outcomes, Ozempic heart disease, multidisciplinary cardiometabolic care, visceral adiposity inflammation, myocardial energetics GLP-1, endothelial dysfunction treatment, atherosclerotic plaque stabilization, diabetic cardiomyopathy, cardiorenal protection, chronic kidney disease, inflammation, metabolic health, autonomic nervous system, clinical collaboration

July 14, 2026

Integrative and Regenerative Sports Chiropractic

Helping Athletes Recover at the Mechanical and Cellular Levels

Sports injuries rarely affect only one part of the body. A painful knee may change how an athlete walks. A shoulder injury may cause the neck and upper back muscles to tighten. An injured spinal disc may affect nearby nerves, muscles, and joints.

This is why sports injury recovery should involve more than simply reducing pain.

At ChiroMed – Integrated Medicine in El Paso, Texas, integrative sports chiropractic focuses on the whole injury. The goal is to address both the mechanical problem and the biological healing process.

A coordinated treatment plan may include:

Chiropractic adjustments
Spinal decompression
Shockwave therapy
MLS laser therapy
Corrective exercise
Functional rehabilitation
Nutrition and functional medicine
Medical evaluation and oversight
Carefully selected regenerative treatments

Each treatment has a different purpose. Chiropractic care may improve joint movement. Spinal decompression may reduce pressure on selected spinal tissues. Shockwave therapy may stimulate healing in stubborn tendon injuries. MLS laser therapy may help control pain and inflammation.

When these methods are used together, the athlete may move beyond short-term symptom control and begin a more active recovery process.

Why Sports Injuries Need a Complete Evaluation

Before treatment begins, the clinical team must understand what was injured and why the problem developed.

Sports injuries may involve:

Muscles
Tendons
Ligaments
Joints
Spinal discs
Nerve roots
Connective tissues
Poor movement patterns
Training errors
Weakness or limited mobility

A complete examination may include range-of-motion testing, strength testing, neurological testing, balance testing, posture analysis, and a review of how the injury happened. Imaging may also be ordered when medically necessary.

This evaluation helps the team determine whether conservative care is appropriate. It also helps rule out fractures, serious ligament injuries, severe nerve compression, infections, or other conditions that may require a specialist.

At ChiroMed, the goal is not to give every athlete the same treatment. The goal is to create a care plan based on the athlete’s injury, health history, sport, physical demands, and recovery goals.

Chiropractic Care Restores Mechanical Movement

Chiropractic care addresses the mechanical side of a sports injury.

When a joint becomes painful or stiff, nearby muscles may tighten to protect it. The athlete may begin moving differently to avoid discomfort. Over time, these changes may place more stress on other parts of the body.

A chiropractor may use adjustments or joint mobilization to improve movement in the spine and extremities. Chiropractic treatment may also help reduce stiffness and support better communication between the joints, muscles, and nervous system.

Sports chiropractic care may include:

Spinal adjustments
Shoulder, hip, knee, or ankle mobilization
Soft-tissue treatment
Movement correction
Stretching
Strengthening exercises
Balance and stability training
Return-to-sport guidance

Research suggests that spinal manipulation may provide modest improvements in pain and physical function for some people with low back pain. It is generally more useful when combined with exercise, education, and active rehabilitation rather than used as a stand-alone treatment (Paige et al., 2017).

At ChiroMed, chiropractic care is one part of a larger recovery plan. Improving joint movement may help the athlete perform rehabilitation exercises with less discomfort and better control.

Spinal Decompression May Reduce Pressure

Spinal decompression is a form of controlled mechanical traction. The athlete lies on a treatment table while gentle pulling forces are applied to selected areas of the spine.

The purpose is to reduce mechanical loading on spinal joints, discs, and irritated nerve roots.

Spinal decompression may be considered for selected patients with:

Disc-related neck or back pain
Certain disc bulges or herniations
Radiating arm or leg pain
Sciatica
Nerve irritation
Pain that improves when spinal pressure is reduced

Supporters of spinal decompression suggest that lowering pressure around a disc may help fluid and nutrients move through the surrounding tissues. This process may create a better environment for recovery.

However, decompression should not be described as a guaranteed way to pull every disc back into position. Results vary, and research on motorized spinal decompression remains limited (Macario et al., 2006).

At ChiroMed, decompression may be used as a supportive treatment when the clinical examination suggests that reducing spinal loading could help. It is normally paired with chiropractic care, exercise, and movement training.

Several clinical resources describe how decompression may be used alongside chiropractic adjustments, laser therapy, and shockwave treatment. Decompression reduces mechanical stress, while the other treatments address joint movement, pain, and irritated soft tissues (Freedom Chiropractic Spine and Injury Center, 2025; Sleppy Chiropractic Family Wellness Center, n.d.).

Shockwave Therapy Stimulates Stubborn Tissues

Shockwave therapy uses controlled acoustic pressure waves. These waves are delivered through the skin into a painful tendon, muscle attachment, or other selected soft tissue.

Shockwave therapy is sometimes described as breaking down scar tissue. However, the healing response is more complex than simply destroying scar tissue.

The acoustic waves may influence:

Local blood flow
Pain sensitivity
Collagen remodeling
Cellular signaling
Tendon healing
The body’s repair response

Shockwave therapy is commonly used for long-lasting conditions such as:

Plantar fasciitis
Achilles tendinopathy
Patellar tendinopathy
Tennis elbow
Golfer’s elbow
Calcific shoulder tendinopathy
Rotator cuff pain
Chronic muscle and tendon injuries

Research suggests that shockwave therapy may improve pain and function in several tendon conditions. Results depend on the type of injury, the treatment settings, and whether the patient follows a progressive rehabilitation program (Elgendy et al., 2024).

Shockwave therapy does not replace strengthening. Instead, it may reduce pain and stimulate tissue activity, allowing the athlete to perform the exercises needed to rebuild strength more effectively.

At ChiroMed, shockwave treatment may be combined with chiropractic care. The chiropractic adjustment addresses restricted joint movement, while shockwave therapy targets damaged or painful soft tissues around the joint.

MLS Laser Therapy Supports Cellular Activity

MLS laser therapy is a form of photobiomodulation. It uses selected wavelengths of red and near-infrared light to reach injured tissues.

The light interacts with structures inside cells, including the mitochondria. Mitochondria help produce the energy cells need to carry out normal functions.

Photobiomodulation may affect:

Cellular energy production
Local circulation
Inflammatory signals
Pain signals
Tissue repair activity
Muscle recovery

MLS laser therapy may be included in care plans for:

Muscle strains
Ligament sprains
Tendon irritation
Joint pain
Neck or back pain
Some nerve symptoms
Post-exercise soreness

Research on laser treatment is promising for certain injuries, but the results are not uniform across all conditions. Treatment success depends on the wavelength, dose, power, treatment time, tissue depth, and diagnosis.

Systematic reviews suggest that photobiomodulation may help reduce pain in some tendon disorders and ankle sprains. However, evidence for swelling, function, and long-term recovery is less certain (Alayat et al., 2024; Tripodi et al., 2021).

At ChiroMed, laser therapy may be used after an adjustment, decompression session, or rehabilitation treatment. Reducing pain and irritation may help the athlete move more comfortably and take part in active recovery.

What About Peptide Therapy?

Peptides are short chains of amino acids. The body naturally uses peptides as signaling molecules. They help control many processes, including hormone activity, inflammation, metabolism, and tissue function.

Some peptide medications are approved by the U.S. Food and Drug Administration for specific medical conditions. However, several peptides promoted online for sports recovery have not been proven safe and effective through large human studies.

Examples often discussed in sports recovery include BPC-157 and TB-500. Most claims about these products come from laboratory or animal research. Strong human evidence remains limited.

Peptide therapy should not be treated like a basic vitamin injection. It requires:

A medical evaluation
A clear diagnosis
Review of the peptide’s approval status
Discussion of possible side effects
Medication interaction screening
Reliable product sourcing
Follow-up monitoring
Review of sports anti-doping rules

BPC-157 and TB-500 are prohibited for competitive athletes under anti-doping rules. Athletes should check every medication, injection, and supplement before using it (U.S. Anti-Doping Agency, n.d.; World Anti-Doping Agency, 2026).

At ChiroMed, discussions of advanced medical or regenerative treatments should occur under qualified medical oversight. Peptides should never replace proven treatments such as proper diagnosis, rehabilitation, sleep, nutrition, and gradual return to activity.

A Multidisciplinary Team at ChiroMed

ChiroMed’s integrative model brings together different healthcare services rather than treating an injury with a single method.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, combines his chiropractic background with advanced practice nursing and functional medicine training.

His published clinical observations emphasize that sports injuries often involve connected problems, including:

Joint restriction
Nerve irritation
Muscle guarding
Inflammation
Weakness
Poor movement control
Nutrition concerns
Sleep problems
Metabolic stress

Dr. Jimenez’s clinical approach combines chiropractic care and rehabilitation to address movement issues, while functional and medical evaluations assess the athlete’s broader health needs.

Dr. Maria Guadalupe Cardenas, MD, serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA. She is board-certified in Internal Medicine and has more than 40 years of experience as an internist. Public provider records identify her Texas medical license as J2933 and her NPI as 1164426748.

This type of multidisciplinary setup is common in integrative and injury-care clinics. Dr. Jimenez directs chiropractic, functional, and movement-based care, while Dr. Cardenas provides medical direction for conditions that require physician evaluation or oversight.

The ChiroMed team may coordinate:

Chiropractic care
Medical evaluation
Functional medicine
Personal injury care
Sports injury treatment
Corrective rehabilitation
Nutrition support
Imaging referrals
Specialist referrals
Advanced conservative therapies

The main advantage is not simply having more treatments available. The advantage is having professionals communicate and select the right treatment for the right patient.

From Symptom Control to Active Recovery

Pain relief is important, but reduced pain does not always mean the injured tissue is ready for full athletic activity.

An athlete must rebuild the body’s ability to handle force, speed, repetition, and sudden changes in direction.

A complete recovery plan may follow these steps:

Identify the injured tissue.
Rule out serious damage.
Reduce pain and harmful mechanical stress.
Restore joint and spinal movement.
Support irritated muscles, tendons, discs, or nerves.
Begin safe rehabilitation.
Rebuild strength, balance, and endurance.
Correct training and movement errors.
Test sport-specific movements.
Return to activity in stages.

Chiropractic care, decompression, shockwave therapy, and MLS laser therapy may support different parts of this process. Rehabilitation provides the active work needed to restore strength and function.

Advanced medical treatments, including peptides, require careful evaluation because approval status, evidence, safety, and anti-doping rules may vary.

The ChiroMed Approach to Sports Injury Recovery

Integrative sports chiropractic examines both the mechanical and cellular aspects of an injury.

Chiropractic care may restore joint movement. Spinal decompression may reduce pressure in selected patients. Shockwave therapy may stimulate stubborn tendon tissues. MLS laser therapy may help control pain and inflammatory activity. Rehabilitation helps the athlete rebuild strength and movement.

At ChiroMed – Integrated Medicine in El Paso, these treatments may be combined with functional medicine, medical oversight, nutrition, and personalized rehabilitation.

The goal is not a temporary quick fix. The goal is to create a clear path from pain and limited movement toward stronger tissues, improved function, and a safer return to sport.

References

Alayat, M. S., et al. (2024). The effectiveness of photobiomodulation therapy for ankle sprain: A systematic review and meta-analysis.

ChiroMed. (n.d.-a). ChiroMed – Integrated Medicine.

ChiroMed. (n.d.-b). Integrated medicine services in El Paso, TX.

DiGrado, M. (n.d.). Deep tissue laser and chiropractic care: How they work together for faster pain relief.

Elite Performance Health Center. (n.d.). Peptide therapy for spinal disc and joint support.

Elgendy, M. H., et al. (2024). Effectiveness of extracorporeal shockwave therapy in treatment of upper and lower limb tendinopathies: A systematic review and meta-analysis.

Freedom Chiropractic Spine and Injury Center. (2025). What are the benefits of combining chiropractic care with laser and decompression?.

Harrington, P. (n.d.). Comparing Class 4 laser therapy, PEMF, and shockwave treatments in chiropractic care.

HealthWorks. (2025). Combining shockwave therapy and chiropractic: A powerful duo for chronic back pain.

Holistiq. (2025). The power of combining chiropractic treatment and shockwave therapy.

InSpine Chiropractic. (n.d.). Shockwave therapy in chiropractic care.

Jimenez, A. (n.d.-a). Dr. Alex Jimenez: Injury rehabilitation and functional medicine.

Jimenez, A. (n.d.-b). Dr. Alexander Jimenez, DC, APRN, FNP-BC.

Jimenez, A. (n.d.-c). Integrative injury recovery clinical discussion [Instagram reel].

Macario, A., et al. (2006). Systematic literature review of spinal decompression through motorized traction for chronic discogenic low back pain.

Orthopedic Specialty Institute. (2025). Peptide injections versus platelet-rich plasma therapy for musculoskeletal injuries: A review of the evidence.

Paige, N. M., et al. (2017). Association of spinal manipulative therapy with clinical benefit and harm for acute low back pain.

Sleppy Chiropractic Family Wellness Center. (n.d.). Beyond the adjustment: How decompression, shockwave therapy, and laser treatment work together.

The Disc Chiropractic. (n.d.-a). Advancing lower back pain relief through spinal decompression and shockwave therapy.

The Disc Chiropractic. (n.d.-b). Integrating shockwave therapy with chiropractic care for lower back pain relief.

Trinity Advanced Health. (n.d.). How chiropractic care, shockwave therapy, and laser therapy work together for soft-tissue injuries.

Tripodi, N., et al. (2021). The effect of red and near-infrared photobiomodulation on tendinopathy.

U.S. Anti-Doping Agency. (n.d.). BPC-157: Experimental peptide prohibited.

World Anti-Doping Agency. (2026). The 2026 prohibited list.

July 13, 2026

Healing Your Spine from the Inside Out

Integrating Chiropractic Care with Regenerative Support

Chronic back or neck pain can slow you down and make simple daily tasks feel hard. Many people try rest, medicine, or basic therapy, yet the pain keeps coming back. Surgery is sometimes suggested, but it often means long recovery times and possible risks. At ChiroMed – Integrated Medicine in El Paso, Texas, there is a better way. Combining chiropractic adjustments with regenerative soft-tissue support repairs the spine from the inside out. Adjustments fix the structure and alignment. Treatments that heal soft tissues stop chronic pain and help rebuild strength without surgery.

This whole-person approach looks at the complete picture. It fits perfectly with ChiroMed’s mission of integrated, holistic healthcare that addresses root causes so you can live life more fully.

Your Spine Is Like a House

Think of your spine like the wooden frame of a house. The bones (vertebrae) are the main beams. The discs, ligaments, tendons, and muscles are the wood, pipes, and supports that hold everything steady.

If the frame leans or shifts, the whole house feels off. Chiropractic adjustments gently move the bones back into better position. This straightens the frame and takes pressure off nerves.

But what if the wood is rotting or the pipes are broken? Straightening the frame alone will not last. The house will lean again. The same thing happens with the spine. If the soft tissues stay damaged or inflamed, pain and weakness return even after good adjustments.

Regenerative therapies, laser support, and shockwave act like a skilled repair crew. They go into damaged areas, reduce swelling, and help new, healthy tissue grow. Massage, soft-tissue work, and spinal decompression then remove daily stress so the repairs hold strong over time. This comprehensive plan delivers lasting results for many people with ongoing spinal problems.

Chiropractic Care: Straightening the Structural Frame

Chiropractic care is the foundation of spine health at ChiroMed. A skilled provider uses gentle, hands-on adjustments or instrument-assisted methods to correct misalignments. These shifts can come from poor posture, old injuries, car accidents, work strain, or years of sitting and bending.

Adjustments help in clear, practical ways:

They restore normal movement in stiff joints.
They reduce pressure on nerves that cause pain, numbness, or tingling.
They improve blood flow and support the body’s natural healing ability.
They help improve posture so everyday activities feel easier.

Chiropractic care offers a non-invasive solution for chronic pain. It helps many people avoid surgery and long-term medication use. Regular adjustments can also enhance range of motion and correct postural issues for a healthier spine.

Reliable health sources confirm that chiropractic adjustments aim to correct alignment problems, ease pain, and support the body’s natural ability to heal itself. Many people seek this care for low back pain, neck pain, and headaches.

When the frame is straight, the rest of the spine can heal better. At ChiroMed, the results improve even more when adjustments are paired with therapies that fix the soft tissues around the bones.

Regenerative and Soft-Tissue Support: Calling in the Repair Crew

Regenerative approaches use the body’s own materials or advanced tools to heal damaged areas. They target the “rotting wood” parts — inflamed discs, strained ligaments, irritated nerves, and weak tendons. These treatments send growth signals that tell cells to repair and rebuild.

Common supportive options that work well with chiropractic include:

PRP-style regenerative injections: Concentrated healing factors from your own blood are placed near injured tissues. They calm inflammation and encourage stronger tissue growth.
Shockwave therapy: Sound waves reach deep into sore muscles and tendons. They increase blood flow, break up scar tissue, and restart the body’s repair process.
Laser support: Special light energy gives cells more power to reduce swelling and speed healing at the deepest level.
Spinal decompression: Gentle stretching creates space between vertebrae. This takes pressure off bulging discs, lets nutrient-rich fluid flow in, and helps discs rehydrate and repair.
Soft-tissue work and massage: These relieve daily stress, improve circulation, and prevent new tissue from tightening again.

These methods help stop the cycle of chronic pain. They reduce swelling, support new tissue growth, and strengthen the areas that hold the spine in place. Many patients notice less pain and improved mobility when these treatments are part of a complete plan.

How Everything Works Together for Lasting Results

The real power comes when chiropractic and regenerative soft-tissue care team up. Adjustments create the right alignment so new tissue can form correctly. Regenerative and soft-tissue support create a healing environment within the tissues, so repairs last longer.

Here is how a typical integrated plan at ChiroMed usually flows:

A careful exam, history, and imaging find the exact problems.
Chiropractic adjustments straighten the frame and improve motion.
Regenerative injections, shockwave therapy, or laser therapy target the damaged soft tissues and nerves.
Spinal decompression and soft-tissue care (including massage and rehab exercises) protect the healing areas from daily stress.
Nutrition counseling, acupuncture, and functional medicine support reduce inflammation and help the whole body recover.

One clear clinical insight is that when regenerative support and chiropractic care are combined, results often last longer. The injections or advanced therapies create a better healing environment inside the tissues. The adjustments keep the joints moving correctly so new tissue forms properly and does not get stressed again.

A combined approach using chiropractic care, spinal decompression, regenerative support, and therapies like shockwave often works better. These treatments create both mechanical and biological conditions that help the body heal and maintain better alignment.

Patients often report meaningful drops in pain, better strength, and the ability to return to work, sports, or family activities. The goal is not just short-term relief. It is lasting repair that helps people avoid surgery and strong medications.

Expert Multidisciplinary Care at ChiroMed in El Paso

ChiroMed – Integrated Medicine brings this complete approach under one roof at 11860 Vista Del Sol Dr Suite 105, El Paso, TX 79936. The clinic has served the community since 1996 with a goal-oriented, honest, and personalized style of care.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, serves as Clinical Director. He is a multi-state-licensed Doctor of Chiropractic and a board-certified Family Nurse Practitioner. His clinical observations show that patients with old injuries, car-accident damage, sciatica, posture problems, and chronic spine pain improve when care targets both tissue repair and nervous-system function. He sees people regain mobility, reduce chronic pain, and return to daily life through personalized, non-invasive plans that combine adjustments, soft-tissue healing, rehabilitation, nutrition, and functional medicine support.

Working alongside him is Dr. Maria Guadalupe Cardenas, MD. She is a board-certified internal medicine physician (NPI #1164426749, Texas MD License #J2933) with over 40 years of experience. She serves as Medical Director and Collaborative Physician. In this multidisciplinary setup — common in integrative and injury care clinics — the MD provides medical oversight, ensures procedural safety, reviews complex health factors, and adds an internal medicine perspective. Dr. Jimenez delivers the hands-on chiropractic and regenerative soft-tissue care. Together with nurse practitioner services, rehabilitation, nutrition counseling, acupuncture, and naturopathic approaches, the team creates one coordinated plan.

This collaboration means patients receive complete care. The structural work (chiropractic), the biological repair (regenerative and soft-tissue support), and the medical guidance all support each other. It is especially helpful for people with personal injuries, sciatica, chronic back pain, or posture problems that have not fully healed with other approaches. The clinic also works closely with patients’ other healthcare providers to ensure seamless care.

Breaking the Pain Cycle and Rebuilding Strength

Poor posture or old injuries often create a cycle: misalignment stresses soft tissues, tissues become inflamed or torn, pain limits movement, and weakness worsens. The integrated approach at ChiroMed breaks this cycle at every level.

Chiropractic restores alignment and motion. Regenerative and soft-tissue therapies heal and strengthen the supporting structures. Decompression, massage, and rehab exercises protect the repairs from daily stress. Nutrition and lifestyle support help the whole body recover. Over time, many people feel less pain, stand taller, move more freely, and enjoy activities again.

This path focuses on root causes instead of just masking symptoms. It supports the body’s natural ability to heal while giving it the right tools and environment to succeed. ChiroMed’s comfortable, fitness-center-like setting and licensed therapists make the journey supportive and goal-focused.

If ongoing spine pain is limiting your life, learning more about this integrated approach may open new options. Many people in El Paso have found real relief and lasting improvement through careful, combined care that repairs the spine from the inside out. Contact ChiroMed – Integrated Medicine today to schedule an evaluation and start your journey toward better strength and freedom from chronic pain.

References

MedlinePlus. (n.d.). Chiropractic. https://medlineplus.gov/chiropractic.html

El Paso Back Clinic. (n.d.). Regenerative therapies combined with chiropractic for pain relief. https://elpasobackclinic.com/regenerative-therapies-combined-with-chiropractic-for-pain-relief/

Personal Injury Doctor Group. (2026). Chiropractic and regenerative therapies for structural support. https://personalinjurydoctorgroup.com/2026/06/30/chiropractic-and-regenerative-therapies-for-structural-support/

Sleppy Chiropractic. (n.d.). Beyond the adjustment: How decompression, shockwave therapy, and laser treatment work together. https://www.sleppy.net/beyond-the-adjustment-how-decompression-shockwave-therapy-and-laser-treatment-work-together/

ChiroMed – Integrated Medicine. (n.d.). Chiropractor El Paso, TX. https://chiromed.com/services/chiropractor-el-paso-tx/

ChiroMed – Integrated Medicine. (n.d.). Home. https://chiromed.com/

Dr. Alexander Jimenez. (n.d.). Injury specialists. https://dralexjimenez.com/

July 3, 2026

Speeding and Aggressive Driving Accidents

ChiroMed Injury Recovery Care in El Paso

Speeding and aggressive driving accidents can change a person’s life in seconds. These crashes occur when drivers ignore traffic laws and show little concern for others’ safety. Common behaviors include driving too fast, tailgating, weaving through traffic, running red lights, failing to yield, and making unsafe lane changes.

These actions are dangerous because they reduce reaction time and make crashes more severe. The National Highway Traffic Safety Administration explains that speeding makes it harder for a driver to steer safely around curves or objects, increases stopping distance, and raises the force of impact during a collision (National Highway Traffic Safety Administration [NHTSA], n.d.). Speeding was also involved in nearly one-third of traffic fatalities nationwide, making it one of the most serious crash risks on American roads (NHTSA, n.d.).

At ChiroMed – Integrated Medicine in El Paso, Texas, accident recovery is approached through a multidisciplinary care model. ChiroMed describes its care as a broad service system that includes chiropractic care, nurse practitioner services, naturopathy, rehabilitation, nutrition counseling, and acupuncture (ChiroMed, n.d.-a). This type of integrated model can be especially useful after high-impact crashes, where the body may need structural care, medical oversight, rehabilitation, and tissue-supportive therapies.

What Is Speeding?

Speeding means more than driving over the posted speed limit. A person can also be speeding when driving too fast for road conditions. This can happen during:

Heavy rain
Night driving
Fog
Road construction
Heavy traffic
Curves or hills
Poor visibility
Wet or damaged roads

A driver may think they are “only going a little fast,” but even a small increase in speed can make a crash more dangerous. At higher speeds, the vehicle needs more distance to stop. The driver also has less time to react. If impact occurs, the body absorbs more force.

The National Safety Council explains that speeding increases crash severity, reduces the effectiveness of safety equipment, and makes roadway safety structures, such as guardrails and barriers, less protective (National Safety Council [NSC], n.d.).

What Is Aggressive Driving?

Aggressive driving is a pattern of unsafe traffic behavior that puts people or property in danger. The Governors Highway Safety Association explains that NHTSA defines aggressive driving as a combination of moving traffic offenses that endanger other people or property (Governors Highway Safety Association [GHSA], 2026).

Aggressive driving may include:

Tailgating
Speeding through traffic
Cutting off other drivers
Making sudden lane changes
Passing improperly
Running red lights
Ignoring stop signs
Blocking another driver from passing
Failing to yield
Driving too close behind motorcycles, bicycles, or smaller vehicles

The Texas Department of Insurance lists speeding, tailgating, red-light running, and weaving in and out of traffic as common aggressive driving behaviors (Texas Department of Insurance [TDI], 2020).

Aggressive Driving vs. Road Rage

Aggressive driving and road rage are not the same thing.

Aggressive driving usually involves dangerous driving violations. Road rage is more extreme. It may involve an intentional violent act with a vehicle, weapon, or physical threat.

A simple way to understand the difference is:

Speeding: Driving too fast for the law or road conditions
Aggressive driving: Committing unsafe driving actions that endanger others
Road rage: Using a vehicle, weapon, or threat to intentionally harm or scare another person

Road rage can begin with aggressive driving, but it goes further. This is why safety groups recommend staying calm, avoiding eye contact with angry drivers, not responding to gestures, and creating distance when possible.

Why These Accidents Happen

Speeding and aggressive driving often come from stress, anger, and impatience. Many drivers become aggressive when they are late, stuck in traffic, or frustrated with slower vehicles.

Common triggers include:

Traffic congestion
Running late
Work stress
Feeling anonymous inside the car
Anger toward another driver
Long commutes
Construction delays
Distracted driving
Poor emotional control

The problem is that aggressive choices do not save much time. A driver may only gain a few seconds, but the risk of injury rises sharply. Zero Deaths Maryland notes that the chance of death or serious injury increases as speed rises, and the risk doubles for every 10 mph over 50 mph (Zero Deaths Maryland, n.d.).

Why High-Speed Crashes Cause Serious Injuries

A high-speed crash is not just a “hard bump.” It is a violent transfer of energy into the body. Even with seat belts and airbags, the spine, muscles, ligaments, joints, discs, and nerves may be injured.

Common injuries after speeding and aggressive driving accidents include:

Whiplash
Neck pain
Back pain
Herniated discs
Sciatica
Pinched nerves
Shoulder injuries
Hip injuries
Knee injuries
Headaches
Muscle strains
Ligament sprains
Joint stiffness
Numbness or tingling
Dizziness
Fatigue
Trouble sleeping

Some symptoms appear right away. Others may take hours or days to show up. This delayed pain can occur because adrenaline initially masks symptoms. Later, inflammation, muscle guarding, and nerve irritation may increase.

ChiroMed’s article on delayed post-accident pain lists symptoms such as neck stiffness, back pain, headaches, shoulder pain, numbness or tingling, dizziness, fatigue, brain fog, irritability, trouble sleeping, and pain that worsens with movement (ChiroMed, n.d.-b).

Why Early Evaluation Matters After a Crash

After an accident, many people say, “I feel fine,” and skip care. This can be risky. Some injuries are not easy to notice at first. A disc injury, ligament sprain, nerve irritation, or soft tissue injury can become more painful as the body reacts to the trauma.

An early evaluation can help identify:

Where the pain is coming from
Whether nerves are irritated
Whether range of motion is limited
Whether imaging may be needed
Whether symptoms match the crash history
Whether conservative care is appropriate
Whether medical oversight is needed

For personal injury cases, documentation also matters. Accurate records may help explain the connection between the accident, injuries, symptoms, treatment plan, and recovery progress.

ChiroMed’s Integrated Injury Care Model

ChiroMed – Integrated Medicine in El Paso presents itself as a clinic that integrates multiple forms of care into a single coordinated system. Its website describes services that include chiropractic care, nurse practitioner services, rehabilitation, nutrition counseling, naturopathy, and acupuncture (ChiroMed, n.d.-a).

ChiroMed’s integrated injury care content also states that an integrated injury clinic can provide a clearer recovery path after an auto accident, work injury, sports injury, or fall by combining chiropractic care, medical oversight, rehabilitation, functional medicine, soft tissue therapy, and advanced treatment options (ChiroMed, n.d.-c).

This approach is helpful because crash injuries often affect multiple body systems. A patient may have spinal pain, nerve irritation, inflammation, muscle guarding, poor sleep, fatigue, and reduced mobility simultaneously. A single treatment may not address the full picture.

Dr. Alex Jimenez and Dr. Maria Cardenas

At ChiroMed, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, brings a combined chiropractic and nurse practitioner background to injury recovery and integrative care. ChiroMed’s website identifies Dr. Jimenez as a dual-licensed professional with chiropractic and advanced practice nurse practitioner credentials (ChiroMed, n.d.-d).

Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, serves as Medical Director, Clinical Director, and Collaborative Physician. ChiroMed lists Dr. Cardenas as NPI #1164426749 and Texas MD License #J2933 (ChiroMed, n.d.-e).

This multidisciplinary setup is common in integrative and injury care clinics. An MD provides medical direction and oversight, while chiropractic care, functional medicine, rehabilitation, and personal injury services are coordinated around the patient’s needs.

Chiropractic Care After Speeding and Aggressive Driving Accidents

Chiropractic care focuses on joint motion, spinal alignment, nervous system stress, and body mechanics. After a crash, the spine can become stiff and irritated. Muscles may tighten to protect the injured area. Joints may lose normal motion. Nerves may become inflamed or compressed.

Chiropractic care may help:

Restore spinal and joint movement
Reduce stiffness
Improve range of motion
Decrease mechanical stress
Support better posture
Reduce muscle guarding
Improve movement patterns

At ChiroMed, chiropractic care may be combined with rehabilitation, functional medicine, and advanced therapies so the patient is not treated with a one-size-fits-all plan.

Spinal Decompression for Disc and Nerve Pain

Spinal decompression may be used for certain neck and back injuries after a crash. It creates controlled negative pressure in the spine. This may help reduce pressure on compressed discs and irritated nerves.

Spinal decompression may be considered for:

Herniated discs
Bulging discs
Sciatica
Neck pain with arm symptoms
Low back pain with leg symptoms
Pinched nerve symptoms

This therapy is not for every patient. A proper exam is needed first. When appropriate, decompression may help reduce local pain and radiating pain while supporting better spinal motion.

MLS Laser Therapy for Inflammation and Tissue Healing

MLS laser therapy uses light-based photobiomodulation. In simple terms, light energy is directed into injured tissue to support cellular repair, reduce inflammation, and calm pain.

After a high-impact crash, MLS laser therapy may be used for irritated muscles, ligaments, tendons, joints, and soft tissues. It is non-surgical and may fit well into a broader injury recovery plan.

Research on photobiomodulation suggests it may help reduce pain in common musculoskeletal conditions, including neck and low back pain (de Oliveira et al., 2022).

Shockwave Therapy for Scar Tissue and Soft Tissue Pain

Shockwave therapy uses deep acoustic sound waves to stimulate injured tissue. It may help improve blood flow, break up painful scar tissue, and support healing in muscles, tendons, and ligaments.

After an accident, some soft-tissue injuries can become stubborn. Pain may continue even after rest, medication, or basic therapy. ChiroMed’s regenerative auto accident recovery content notes that care may include chiropractic treatment, rehabilitation, shockwave therapy, and regenerative options such as PRP, platelet-poor plasma, plasma-based therapies, and MFAT (ChiroMed, n.d.-f).

Shockwave therapy may be useful when tissues need more stimulation to restart the healing process.

Regenerative Therapies: PRP, PFP, and MFAT

Regenerative therapies are designed to support the body’s natural repair process. They are not magic cures, and they do not replace proper rehabilitation. Instead, they may help create a better healing environment when used for the right patient.

Common regenerative options include:

PRP, or Platelet-Rich Plasma: Uses concentrated platelets from the patient’s own blood. Platelets contain growth factors that may support tissue repair.
PFP, or Platelet-Poor Plasma: Uses plasma-based proteins that may help support the healing environment.
MFAT, or Micro-Fragmented Adipose Tissue: Uses processed fat tissue to provide cushioning and healing signals for certain joint and soft tissue injuries.

A review on platelet-rich plasma explains that PRP uses concentrated autologous platelets and is used in musculoskeletal care to support healing in selected injuries (O’Dowd et al., 2022).

Epidural Spinal Injections for Severe Nerve Inflammation

Some crash injuries cause serious spinal nerve irritation. This may lead to shooting pain, sciatica, numbness, tingling, burning pain, or weakness. When conservative care needs support, epidural spinal injections may be considered under medical guidance.

Epidural injections deliver anti-inflammatory medication near irritated spinal nerves. StatPearls explains that epidural steroid injections are used to reduce inflammation and pain in selected spinal conditions (Patel et al., 2024).

These injections should always be based on a proper diagnosis, medical review, and careful patient selection.

IV Infusion Therapy for Recovery Support

After a serious crash, the body may feel worn down. Pain, inflammation, poor sleep, stress, and reduced movement can drain energy. IV infusion therapy delivers hydration, vitamins, and minerals directly into the bloodstream.

IV therapy may support:

Hydration
Nutrient balance
Fatigue recovery
Internal healing support
Wellness during rehabilitation

IV therapy does not replace food, rest, medical care, or exercise. It is best used as part of a larger recovery plan when clinically appropriate.

A ChiroMed-Style Recovery Plan

A clear recovery plan after a speeding or aggressive driving accident may include several steps.

Step 1: Evaluation
The team reviews the crash history, symptoms, range of motion, orthopedic findings, neurological signs, and imaging when needed.

Step 2: Pain and inflammation control
Care may begin with gentle therapies that calm pain, reduce swelling, and improve comfort.

Step 3: Restoring movement
Chiropractic care, decompression, mobility work, and rehabilitation may help the spine and joints move better.

Step 4: Supporting tissue healing
MLS laser therapy, shockwave therapy, PRP, PFP, MFAT, or epidural injections may be considered when appropriate.

Step 5: Rehabilitation
Corrective exercises help rebuild strength, balance, posture, flexibility, and function.

Step 6: Long-term wellness support
Functional medicine, nutrition counseling, hydration, sleep support, and lifestyle planning may help reduce the risk of future injury.

Final Thoughts

Speeding and aggressive driving accidents are not simple fender benders. They can create strong forces that injure the spine, joints, muscles, ligaments, discs, and nerves. Pain may start right away or appear days later.

At ChiroMed – Integrated Medicine in El Paso, the goal is to guide patients through a clear and coordinated recovery process. With Dr. Alex Jimenez, DC, APRN, FNP-BC, leading chiropractic and integrative injury care, and Dr. Maria Guadalupe Cardenas, MD, providing medical direction and collaborative oversight, ChiroMed reflects a multidisciplinary model for accident recovery.

The focus is simple: evaluate the injury, reduce pain, calm inflammation, restore movement, support tissue healing, and help the patient return to daily life with better strength, mobility, and confidence.

References

ChiroMed. (n.d.-a). ChiroMed – Integrated Medicine Holistic Healthcare in El Paso.

ChiroMed. (n.d.-b). Post-Accident Pain: Why Symptoms Are Delayed.

ChiroMed. (n.d.-c). Integrated Injury Care in El Paso, TX.

ChiroMed. (n.d.-d). About Us.

ChiroMed. (n.d.-e). Chiropractor El Paso, TX.

ChiroMed. (n.d.-f). Regenerative Therapy for Auto Accident Injury Recovery.

de Oliveira, M. F., Johnson, D. S., Demchak, T., Tomazoni, S. S., & Leal-Junior, E. C. P. (2022). Low-intensity LASER and LED photobiomodulation therapy for pain control of the most common musculoskeletal conditions. European Journal of Physical and Rehabilitation Medicine, 58(2), 282–289.

Governors Highway Safety Association. (2026). Speeding & aggressive driving.

National Highway Traffic Safety Administration. (n.d.). Speeding and aggressive driving prevention.

National Safety Council. (n.d.). Speeding.

O’Dowd, A., Bowles, R., McKenna, L., & Walters, J. (2022). Update on the use of platelet-rich plasma injections in the management of musculoskeletal injuries. Journal of Clinical Orthopaedics and Trauma, 30, 101917.

Patel, K., Upadhyayula, S., & Patel, R. (2024). Epidural steroid injections. StatPearls. StatPearls Publishing.

Texas Department of Insurance. (2020). Aggressive driving fact sheet.

Zero Deaths Maryland. (n.d.). Speed and aggressive driving.

July 3, 2026

SGLT2 Inhibitors in Diabetes & Cardio-Renal Benefits

Understand the role of SGLT2 inhibitors in providing cardio-renal benefits for better health management for the body.

Abstract

In this educational post, I share a clear, first-person journey through modern, evidence-based strategies that leverage SGLT2 inhibitors for cardio-renal protection in patients with diabetes and metabolic syndrome. We will explore the intricate connections between Type 2 Diabetes, Chronic Kidney Disease (CKD), and Cardiovascular Disease, and I will guide you through a detailed case study that showcases a modern, holistic approach to treatment. Drawing from my clinical observations and our multidisciplinary practice in El Paso, Texas, I explain how we integrate chiropractic care, internal medicine oversight, functional medicine, rehabilitation, and personal injury care to optimize outcomes. I also introduce our team structure, in which Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933), serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA, alongside my role as a Doctor of Chiropractic and an advanced practice registered nurse. This post offers an accessible, step-by-step narrative with clinically relevant physiology, treatment rationales, and actionable protocols to support whole-person cardio-renal health.

My Path Toward Cardio-Renal Integration in Diabetes Care

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Over the years, my clinical practice has focused on the intersection of metabolic health, musculoskeletal function, and neurophysiology—an integrative space where biochemical and biomechanical pathways meet. Early in my journey, a personal encounter with a loved one’s complications from diabetes impressed upon me how seemingly small choices—nutrition, movement, adherence, and foot care—can transform outcomes. Later, my formal training and work in functional medicine and advanced chiropractic biomechanics refined my approach to combine precise manual therapies, exercise rehabilitation, and medically supervised pharmacologic strategies.

Today, I use modern research on SGLT2 inhibitors to enhance cardio-renal outcomes. At the same time, our clinic’s multidisciplinary model ensures that each intervention is medically appropriate, safely combined, and tailored to the patient’s unique physiology. Our work is about reducing risk, restoring function, and improving quality of life.

Our Integrative Practice Model: A Symphony of Care

At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we have cultivated a unique environment where different disciplines work in concert for the patient’s total well-being. This multidisciplinary setup is typical of progressive integrative and injury-care clinics.

Medical Management: Our practice is guided by the extensive medical expertise of Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a board-certified internist with an impressive 40-year career. As our Medical Director and Collaborative Physician, she provides essential medical oversight of our patients’ complex conditions, including prescribing and managing medications.
Chiropractic and Functional Medicine: I, Dr. Alex Jimenez, lead our team with a focus on chiropractic and functional medicine, addressing the body’s structural integrity, biomechanics, and underlying physiological imbalances. This approach is powerful for managing musculoskeletal complications, improving mobility, and reducing pain.
Comprehensive Services: This collaborative model allows us to offer a full spectrum of services under one roof, including functional medicine, personal injury care, rehabilitation, neuromuscular re-education, and lifestyle medicine.

This synergy ensures that a patient with diabetes receives not only state-of-the-art medical treatment for their blood sugar and organ protection, but also chiropractic adjustments to improve nervous system function, nutritional counseling to overhaul their diet, and physical rehabilitation to help them move again. It’s a 360-degree approach to health that treats the person, not just the disease.

A Patient’s Journey: From Uncontrolled Diabetes to Renewed Health

Let me introduce you to a patient we’ll call R.B., a case that perfectly illustrates the challenges and opportunities in modern diabetes care. When R.B. first came to our clinic, he was a 73-year-old Hispanic male with a 12-year history of type 2 diabetes, hypertension, and hyperlipidemia, and he was struggling despite being on several medications.

Patient Profile & Medications:

Metformin 1000 mg BID
Glipizide 10 mg BID with meals
Linagliptin (Tradjenta) 5 mg daily: A new DPP-4 inhibitor started shortly before his visit.
Losartan 100 mg daily: For hypertension.
Hydrochlorothiazide 25 mg daily: A diuretic for blood pressure.
Simvastatin 40 mg daily: For high cholesterol.
Glargine (Lantus) Insulin: Recently reduced from 60 units to 42 units.

His lab work painted a concerning picture. His hemoglobin A1C was a staggering 10.2%. His kidney function was declining, with an estimated Glomerular Filtration Rate (eGFR) of 43 and a creatinine level of 1.5. Clinically, he was experiencing dangerously high blood sugars during the day (200-300 mg/dL) yet was waking up with nocturnal hypoglycemia.

This patient was referred to our endocrinology service after a recent hospitalization for hyperglycemia and acute kidney injury. For five years, he had been considered “stable”, but his A1C had never dropped below 8%. This is a critical point: stability at a poor baseline is not true control. He had the trifecta of risk factors that recent clinical trials have focused on:

Type 2 Diabetes: With a high A1C of 10.2%.
Increased Cardiovascular Risk: Due to co-existing hypertension and hyperlipidemia.
Chronic Kidney Disease (CKD): Evidenced by his low eGFR of 43.

Treatment Plan Part 1: Building a Foundation Through Education and Trust

The first step was not to add more medications but to address foundational issues. The patient was glucotoxic—a state where high blood sugar impairs insulin secretion and increases insulin resistance.

Comprehensive Diabetes Self-Management Education (DSME)

We started with intensive education. I discovered R.B. didn’t understand what his medications did. His most significant barrier was a profound fear of low blood sugar. To avoid it, he would preemptively eat carbohydrates throughout the day, driving his blood sugars sky-high. His long-acting insulin would then cause his sugar to plummet at night.

To break this cycle, we made two immediate changes:

We stopped the glipizide, a sulfonylurea drug notorious for causing hypoglycemia.
We further decreased his Lantus (glargine) dose to prevent nighttime lows.

Overcoming Barriers to Technology

A major point of resistance was his refusal to use a Continuous Glucose Monitor (CGM). He was terrified of a “big needle” staying under his skin. I showed him a demo CGM device and the tiny, flexible filament—not a needle—that actually sits under the skin. His fear vanished. We applied a sample sensor and ordered his supplies.

Finally, I ordered a C-peptide level. I explained this test to patients using an analogy: “The C-peptide is the candy wrapper, and insulin is the candy. If I see a lot of wrappers in your blood, I know your body is still making its own candy.”

Cardio-Renal Pathophysiology Made Simple

To treat effectively, we must understand the intertwined physiology. I explain these concepts to patients using clear analogies:

When blood glucose is high, think of syrup or honey. It is sticky and viscous. Your heart has to pump harder to move that thickened fluid, increasing cardiac workload.
Prolonged exposure to high sugar is inflammatory. If you hold a candy against your cheek for an hour, the tissue feels irritated. Similarly, hyperglycemia stiffens vessel walls and damages the vascular endothelium, including in the kidneys and heart.

The physiology behind these analogies is complex:

Kidney-glucose dynamics: In hyperglycemia, the kidney’s proximal tubules upregulate SGLT2 transporters, reabsorbing more glucose and sodium. This maladaptive conservation sustains hyperglycemia and reduces sodium delivery to the macula densa, blunting tubuloglomerular feedback and driving glomerular hyperfiltration. Over time, this causes podocyte injury, mesangial expansion, and glomerulosclerosis.
Heart-kidney axis: Volume overload and neurohormonal activation (RAAS, SNS) perpetuate cardiac remodeling. Increased venous congestion impairs renal perfusion, further activating RAAS—a vicious cycle worsened by insulin resistance and endothelial dysfunction.
Inflammation and fibrosis: Chronic hyperglycemia and oxidative stress increase TGF-β, NF-κB, and AGE-RAGE signaling, promoting fibrosis in renal and cardiac tissue.
Autonomic balance: Sympathetic overdrive elevates heart rate and vascular tone, harming diastolic filling and renal microcirculation.

Cardiometabolic Risk Causes & Effects- Video

SGLT2 Inhibitors: How They Work and Why We Use Them

SGLT2 inhibitors (such as empagliflozin, dapagliflozin, canagliflozin, and ertugliflozin) reduce blood glucose by promoting glucose excretion in the urine. Their benefits extend far beyond glucose lowering.

Key mechanisms:

Renal tubular transport modulation: By blocking sodium-glucose co-transport in the proximal tubule, they increase natriuresis (sodium excretion) and osmotic diuresis (water excretion).
Restoration of tubuloglomerular feedback: More sodium delivery to the macula densa improves afferent arteriolar tone, reducing intraglomerular pressure and mitigating hyperfiltration.
Hemodynamic effects: Reduced preload and afterload benefit cardiac function, leading to fewer heart failure events.
Metabolic shifts: Mild ketogenesis, lower insulin levels, improved insulin sensitivity, and weight reduction collectively support metabolic health.

Why we integrate them:

Robust evidence demonstrates cardio-renal benefits independent of A1c.
They complement lifestyle and biomechanical interventions by reducing congestion, improving energy utilization, and lowering systemic inflammation.
They fit the functional medicine goal of addressing root contributors—hemodynamics, energy metabolism, and renal microvascular stress.

Treatment Plan Part 2: Two Weeks Later – Progress and Precision

Two weeks later, the results were encouraging: blood sugar levels averaged in the 180s, and nocturnal hypoglycemia was gone. The C-peptide test came back within the normal range, confirming his pancreas was still producing insulin.

With his glucotoxicity resolving, it was now safe to introduce a more advanced therapy. Based on his CKD and cardiovascular risk profile, the clear choice was an SGLT2 inhibitor. We started him on Dapagliflozin (Farxiga) 5 mg daily and reduced his glargine dose again.

Clinical Indications and Patient Selection

Our internal medicine oversight by Dr. Cardenas ensures evidence-based selection for SGLT2 inhibitors:

Type 2 diabetes with high cardiovascular risk or existing heart failure.
Chronic kidney disease, with or without diabetes, particularly albuminuric CKD.
Heart failure across ejection fraction phenotypes (HFrEF and HFpEF), per modern trials.

We assess baseline eGFR, albumin-to-creatinine ratio, blood pressure, volume status, and existing medications, such as diuretics and RAAS inhibitors, to anticipate risks.

Safety and Monitoring Protocols

Under Dr.Cardenas’ss medical direction, we implement strict monitoring:

Renal function: Expect a modest, temporary dip in eGFR initially; monitor for stabilization.
Volume status: Monitor for dizziness or hypotension; adjust diuretics as needed.
Genitourinary infections: Counsel on hygiene; monitor for mycotic infections.
Euglycemic ketoacidosis: Rare; educate on sick-day rules, hydration, and carb intake.
Foot care: Double down on peripheral vascular assessments and neuropathy screening.

Treatment Plan Part 3: Three Months – Remarkable Improvement

Three months after his initial visit, the transformation was undeniable.

A1C: Dropped from 10.2% to 8.2%.
Creatinine: Improved from 1.54 to 1.3.
eGFR: Increased from 43 to 53.

His kidney function was actively improving! I explained it to him like this: “Remember when I told you high blood sugar makes your blood thick and sticky, like syrup? It forces your kidneys to work overtime. Now that your sugars are better, your blood flows more easily, and your kidneys can filter more efficiently.”

We also switched him from linagliptin to semaglutide (Ozempic) 0.5 mg weekly. Semaglutide is a GLP-1 receptor agonist that not only improves blood sugar control but also promotes weight loss and provides robust cardiovascular protection.

Integrative Chiropractic Care and Rehabilitation

Chiropractic care is not an add-on—it is integral to our approach.

Autonomic modulation: Dysautonomia in diabetes and heart failure fuels sympathetic dominance. Targeted spinal adjustments and vagal-stimulating breathwork can enhance HRV, reduce resting sympathetic tone, and improve baroreflex sensitivity. This aids renal perfusion and cardiac efficiency.
Thoracic mobility and respiration: Restricted rib and thoracic spine motion compromises ventilation and venous return. Mobilization improves diaphragmatic excursion, reduces intrathoracic pressures, and supports cardiac filling, synergizing with the preload reduction from SGLT2 inhibitors.
Gait mechanics and peripheral circulation: Foot and ankle alignment influence plantar pressure and ulcer risk. We correct biomechanical imbalances and prescribe footwear or orthotics.
Rehabilitation for Capacity Building: Our graded rehabilitation protocols restore functional capacity. Improved skeletal muscle mass enhances glucose uptake (GLUT4-mediated), reduces insulin resistance, and supports cardiac output by improving peripheral oxygen utilization.

From my clinical observations, integrating musculoskeletal optimization with metabolic therapies improves adherence and functional outcomes. Patients who receive targeted manual therapy and movement training are more likely to sustain walking programs, which lower A1C, reduce blood pressure, and enhance heart rate variability.

Treatment Plan Part 4: Seven Months – Approaching Full Remission

Seven months from his first visit, R.B. was a new person.

Blood Sugar Average: Now 150 mg/dL, with no lows.
A1C: Further improved to 7.2%, a 3-point drop!
Creatinine: Now 1.25, within the normal range.
eGFR: Stabilized at an improved 55.

Most remarkably, he was achieving this without needing mealtime insulin. The combination of Dapagliflozin and Semaglutide was working so effectively that his body’s own insulin, paired with better lifestyle choices, was enough. We officially stopped his prandial lispro.

Why This Matters: From Risk Reduction to Life Quality

This case highlights a new paradigm for diabetes care. We must stop fixating on A1C alone and consider the non-glycemic benefits of medications. By combining SGLT2 inhibitors with integrative chiropractic care, functional medicine, and rehabilitation, we address the mechanisms that drive heart and kidney decline while restoring movement, autonomy, and resilience. The evidence is strong, the physiology compelling, and the patient stories motivating. With cohesive medical oversight from Dr. Maria Guadalupe Cardenas, MD, and a unified clinical team, our approach is safe, rigorous, and deeply human.

Key Takeaways

SGLT2 inhibitors provide robust cardio-renal benefits through hemodynamic, metabolic, and microvascular mechanisms.
Integrative chiropractic care enhances autonomic balance, respiration mechanics, and peripheral circulation, synergizing with pharmacotherapy.
Medical oversight by Dr. Maria Guadalupe Cardenas, MD ensures safety, appropriate selection, and precise monitoring.
Functional medicine and rehabilitation embed behavior change and strengthen physiology for lasting outcomes.
Multidisciplinary coordination delivers comprehensive, patient-centered cardio-renal care.

References

American Association of Clinical Endocrinology. (2022). AACE Comprehensive Type 2 Diabetes Management Algorithm.
American Diabetes Association. (2024). Standards of Medical Care in Diabetes—2024. Diabetes Care.
Anker, S. D., Butler, J., Filippatos, G., et al. (2021). Empagliflozin in Heart Failure with a Preserved Ejection Fraction. New England Journal of Medicine.
Cannon, C. P., Pratley, R., Dagogo-Jack, S., et al. (2020). Cardiovascular outcomes with ertugliflozin in type 2 diabetes. New England Journal of Medicine.
Heerspink, H. J. L., Stefansson, B. V., Correa-Rotter, R., et al. (2020). Dapagliflozin in patients with chronic kidney disease. New England Journal of Medicine, 383(15), 1436–1446.
Heidenreich, P. A., Bozkurt, B., Aguilar, D., et al. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation.
KDIGO. (2022). KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
Marso, S. P., Bain, S. C., Consoli, A., et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine, 375(19), 1834–1844.
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., et al. (2019). Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. New England Journal of Medicine.
Perkovic, V., Jardine, M. J., Neal, B., et al. (2019). Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. New England Journal of Medicine, 380(24), 2295–2306.
The EMPA-KIDNEY Collaborative Group. (2022). Empagliflozin in patients with chronic kidney disease. New England Journal of Medicine.
Zelniker, T. A., Wiviott, S. D., Raz, I., et al. (2019). SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. The Lancet, 393(10166), 31–39.
Zinman, B., Wanner, C., Lachin, J. M., et al. (2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine.

Additional Clinical Observations

SEO tags: SGLT2 inhibitors, cardio-renal benefits, chronic kidney disease, heart failure, type 2 diabetes, integrative chiropractic care, functional medicine, internal medicine oversight, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, El Paso clinic, diabetes management, rehabilitation, autonomic balance, thoracic mobility, microvascular health, GLP-1 agonists, A1C, eGFR, hypoglycemia, Ozempic, Farxiga, patient education, holistic healthcare, cardio-renal protection, empagliflozin, dapagliflozin, canagliflozin, ertugliflozin, ADA guidelines, AACE guidelines, albuminuria, RAAS system, euglycemic DKA, personal injury care, Mission Plaza Injury Medical Clinic

July 2, 2026

Cardiometabolic Research Advances Using GLP-1 Receptor Therapy

Find out about GLP-1 receptor therapy on cardiometabolic health and its revolutionary role in modern medicine and patient care.

Abstract

Hello, I’m Dr. Alex Jimenez, and I am honored to share transformative insights into managing cardiovascular and metabolic conditions, such as type 2 diabetes. This educational post explores a significant shift in our medical understanding, moving from a purely glucose-centric model to a comprehensive, risk-reduction strategy. Here, we will journey through the latest findings from leading researchers, backed by robust, evidence-based studies, to understand this new paradigm. We’ll delve into the mechanisms of two groundbreaking classes of medications—SGLT2 inhibitors and GLP-1 receptor agonists—and their profound benefits for cardiovascular and renal health, often independent of their glucose-lowering effects. We will also discuss how our multidisciplinary team at Injury Medical Clinic PA, including the invaluable medical direction of Dr. Maria Guadalupe Cardenas, MD, integrates these advancements with integrative chiropractic care, functional medicine, and rehabilitation to provide a truly holistic treatment plan for our patients in El Paso, Texas. This post aims to illuminate the interconnectedness of cardiac, metabolic, and kidney health and present a collaborative path forward for optimal patient outcomes.

Our Collaborative and Integrative Practice at Injury Medical Clinic PA

Before we delve into the clinical science, I want to take a moment to explain our unique approach to patient care here in El Paso, Texas. At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, we have built a truly multidisciplinary practice. I am Dr. Alex Jimenez, and my credentials include DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST. My passion lies in functional medicine and chiropractic care, focusing on the body’s innate ability to heal and the musculoskeletal system’s foundational role in overall health.
A cornerstone of this model is my collaboration with Dr. Maria Guadalupe Cardenas, MD. With over 40 years of experience as a board-certified internist, Dr. Cardenas serves as our Medical Director and Collaborative Physician (NPI #1164426749, Texas MD License #J2933). Her extensive expertise in internal medicine provides essential medical oversight and direction, allowing us to seamlessly merge advanced medical protocols with chiropractic, functional medicine, rehabilitation, and personal injury care.
Our model is built on the synergy between different disciplines:

Medical Oversight (Dr. Cardenas): Provides diagnoses, prescribes medications like the advanced therapies we will discuss today, and oversees the overall medical treatment plan, ensuring patient safety and efficacy.
Chiropractic and Functional Medicine (Dr. Jimenez): I focus on identifying and addressing the root causes of dysfunction. Through chiropractic adjustments, we restore proper nerve function and biomechanics. With functional medicine, we analyze a patient’s genetics, lifestyle, and environment to correct underlying imbalances in metabolism, inflammation, and gut health.
Integrated Services: Together, we manage personal injury cases, rehabilitation, nutritional counseling, and chronic disease management. This team-based approach ensures that a patient with diabetes, for example, not only receives the latest medications but also benefits from dietary overhauls, targeted supplementation, and structural care to improve insulin sensitivity and reduce systemic inflammation. This is the essence of integrative medicine—uniting the best of multiple worlds for superior patient outcomes.

The Critical Link Between Diabetes and Cardiovascular Disease

For a long time, the primary focus in managing type 2 diabetes was on lowering blood glucose. While important, this approach was incomplete. We now have an overwhelming body of evidence showing that people with diabetes face a significantly elevated risk for Atherosclerotic Cardiovascular Disease (ASCVD), which includes coronary heart disease, stroke, and peripheral arterial disease. In fact, ASCVD is the leading cause of death for individuals with diabetes.

Consider this startling fact: over 70% of individuals with diabetes over the age of 65 will likely succumb to heart disease or a stroke.
Following a heart attack (myocardial infarction or MI), people with diabetes have a much higher mortality risk and a poorer long-term prognosis.
These grim outcomes persist even when blood sugar levels are well-controlled, and they affect individuals with both type 1 and type 2 diabetes.

This reality has forced a paradigm shift in how we manage these interconnected conditions. The focus has expanded from aggressive glucose reduction to a holistic strategy to reduce overall cardiovascular and renal risk. This involves managing not just blood sugar, but also blood pressure, cholesterol levels, weight, physical activity, and smoking cessation. For the first time in my career, all the major guideline-issuing bodies—including the American College of Cardiology (ACC), the American Heart Association (AHA), the American Diabetes Association (ADA), and the Kidney Disease: Improving Global Outcomes (KDIGO)—are in complete agreement on this new, integrated approach to care. This consensus marks a monumental step forward, allowing us to view and treat our patients through a unified, comprehensive lens.

Rethinking Treatment Algorithms: A Risk-Based Approach

This new paradigm is reflected in the latest treatment algorithms from the American Diabetes Association. The guidelines now emphasize a risk-stratified approach. For any patient with type 2 diabetes who has established ASCVD, heart failure, chronic kidney disease (CKD), or is at high risk for developing these conditions, the recommendation is to concurrently address all risk factors and prioritize specific classes of medications.
The algorithm directs us to move beyond traditional first-line agents like metformin alone and immediately consider two powerful classes of drugs:

SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitors
GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists

These medications are now recommended as foundational therapies for high-risk patients precisely because they have demonstrated proven cardiovascular (CV) benefits in large-scale clinical trials. The choice between them, or the decision to use them in combination, depends on patient-specific factors, comorbidities, and preferences. This marks a significant departure from simply trying to lower the A1C; it’s about proactively protecting the heart and kidneys.

The History and Evolution of Diabetes Medication Trials

How did we arrive at this pivotal moment? The story begins around 2008, when the U.S. Food and Drug Administration (FDA) issued mandatory guidance for all new antidiabetic medications. The FDA required pharmaceutical companies to conduct long-term Cardiovascular Outcomes Trials (CVOTs). The primary goal was to ensure that these new drugs did not increase the risk of Major Adverse Cardiovascular Events (MACE)—a composite of non-fatal heart attack, non-fatal stroke, and cardiovascular death.
This mandate was a direct response to past experiences where certain drugs, such as rosiglitazone (Avandia) and others like Vioxx, were later found to cause cardiovascular harm. Earlier studies were often too short, underpowered, or poorly designed to detect these risks. The FDA’s new requirement forced the industry to conduct large, well-designed, placebo-controlled trials that were robust enough to demonstrate safety or non-inferiority.
What happened next was truly surprising. As the results of these CVOTs began to be published, starting with the EMPA-REG OUTCOME trial for empagliflozin (Jardiance) in 2015, researchers discovered something extraordinary. These new drugs weren’t just safe—some of them were actively protective.

Empagliflozin (Jardiance), an SGLT2 inhibitor, was the first to show a significant reduction in MACE, CV death, and hospitalization for heart failure.
Liraglutide (Victoza), a GLP-1 receptor agonist, followed in 2016 with the LEADER trial, also demonstrating significant cardiovascular benefits.

These unexpected findings of superiority, not just safety, were game-changers. They provided the evidence needed to completely overhaul the clinical guidelines and place these drug classes at the forefront of managing patients with cardiovascular, metabolic, and renal disease.

A Deeper Dive into SGLT2 Inhibitors

Let’s explore the SGLT2 inhibitor class more closely. These medications work by blocking glucose reabsorption in the kidney, causing excess sugar to be excreted in the urine. While this helps lower blood glucose, their profound cardiovascular and renal benefits appear to stem from multiple other mechanisms.

Landmark Cardiovascular Outcomes Trials for SGLT2 Inhibitors

Several major CVOTs have established the benefits of this class:

EMPA-REG OUTCOME (empagliflozin/Jardiance): This trial was a watershed moment. It showed a highly statistically significant reduction in MACE, CV death, and hospitalization for heart failure.
CANVAS Program (canagliflozin/Invokana): Demonstrated significant reductions in MACE and hospitalization for heart failure.
DECLARE-TIMI 58 (dapagliflozin/Farxiga): While it didn’t show a significant reduction in MACE, it showed a substantial and statistically significant reduction in the risk of hospitalization for heart failure.
VERTIS-CV (ertugliflozin/Steglatro): Also showed a significant reduction in hospitalization for heart failure risk (a 30% relative risk reduction).

The consistent and powerful effect on reducing hospitalizations for heart failure across the class is particularly noteworthy and has led to their widespread adoption in cardiology.

The Multifaceted Mechanisms of SGLT2 Inhibitors

What makes these drugs so effective? The benefits go far beyond simple glucose lowering. Some of the proposed mechanisms that contribute to their cardioprotective and renoprotective effects:

Hemodynamic Effects: SGLT2 inhibitors have a mild diuretic effect, which helps reduce blood pressure by about 3-5 mmHg systolic. This is achieved through natriuresis, or the excretion of sodium and water, which reduces fluid volume and preload on the heart.
Reduced Glomerular Pressure: In the kidneys, these drugs reduce pressure within the glomerulus (the kidney’s filtering unit). This is a key theorized mechanism for their nephroprotective (kidney-protecting) effects, slowing the progression of diabetic kidney disease.
Metabolic Shifts: SGLT2 inhibitors promote a slight shift towards ketosis. The heart is a unique metabolic organ that can efficiently use ketones as a fuel source. This “super fuel” improves myocardial efficiency and function, especially in a stressed or failing heart.
Systemic Benefits: They also contribute to a modest weight loss (around 5-7 pounds), reduce inflammation, decrease oxidative stress, and may improve endothelial function and stabilize atherosclerotic plaques.
Improved Myocardial Energetics: By reducing the workload on the heart (via lower blood pressure and volume) and providing a more efficient fuel source (ketones), these drugs improve the overall energy balance and function of the heart muscle.

SGLT2 Inhibitors in Heart Failure and Kidney Disease

The benefits of SGLT2 inhibitors have been so profound that their use has expanded to patients without diabetes.

Heart Failure Trials

DAPA-HF and EMPEROR-Reduced: These trials studied dapagliflozin and empagliflozin, respectively, in patients with heart failure with reduced ejection fraction (HFrEF). Both showed a remarkable 25-26% relative risk reduction in the composite outcome of cardiovascular death or hospitalization for heart failure, regardless of whether the patients had diabetes.
EMPEROR-Preserved: This was the first trial to show a meaningful benefit in patients with heart failure with preserved ejection fraction (HFpEF), a very common and difficult-to-treat type of heart failure, particularly in older adults, women, and those with obesity. Empagliflozin reduced the primary composite endpoint by 21%.

Kidney Disease Trials

The evidence for kidney protection is just as compelling:

DAPA-CKD (dapagliflozin): This trial was stopped early due to overwhelming efficacy. It showed a 39% reduction in the risk of progression of kidney disease.
EMPA-KIDNEY (empagliflozin): Also demonstrated a significant 28% reduction in the risk of kidney disease progression or cardiovascular death.
CREDENCE (canagliflozin): Showcased a 30% reduction in the risk of kidney failure and cardiovascular events in patients with type 2 diabetes and kidney disease.

These trials have firmly established SGLT2 inhibitors as a cornerstone therapy for chronic kidney disease, even in patients without diabetes.

Understanding the Incretin Effect: TheBody’ss Natural Glucose Response System

For years, the management of type 2 diabetes centered on a few key strategies. However, a fascinating discovery completely shifted our understanding and opened the door to a new class of powerful therapies. Researchers observed a peculiar phenomenon: when people consumed glucose orally (by drinking it), their bodies produced a much more robust insulin response to lower blood sugar than when the same amount of glucose was administered intravenously (IV). This observation led them to a logical conclusion: there must be something happening in the gut when food is ingested that signals the pancreas to ramp up insulin production.
This phenomenon was termed the “incretin effect.” The “somethings” responsible were identified as gut hormones called incretins, primarily glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

The Process: When you eat, food travels to your stomach and intestines. Specialized cells in your gut (L-cells) detect the presence of nutrients and release GLP-1 and GIP into your bloodstream.
The Signal: These hormones then travel to the pancreas, where they act as messengers. They bind to receptors on pancreatic beta cells, stimulating the cells to release insulin.
The Result: This insulin release helps your body’s cells take up glucose, effectively lowering your blood sugar levels after a meal.

Crucially, this entire process is glucose-dependent. This means the incretins only stimulate insulin release when blood sugar levels are high, as they are after a meal. This built-in safety mechanism significantly reduces the risk of hypoglycemia (dangerously low blood sugar) when these pathways are targeted with medication, especially compared to older diabetes drugs.

The Blunted Incretin Effect in Type 2 Diabetes

One of the key physiological defects we see in patients with type 2 diabetes is a blunted or even absent incretin effect. Their bodies produce insufficient amounts of native GLP-1 in response to food. This deficiency contributes significantly to the hallmarks of the disease:

Poor Post-Meal Glucose Control: Without a strong incretin signal, the pancreas doesn’t release sufficient insulin after eating, resulting in prolonged periods of high blood sugar.
Dysregulated Appetite: Native GLP-1 also plays a critical role in promoting satiety, or the feeling of fullness. Low levels of this hormone can lead to a state of poor satiety, contributing to overeating and the obesity that is so often a comorbid condition with type 2 diabetes.
Excess Glucagon Secretion: GLP-1 normally helps suppress the release of another hormone called glucagon. Glucagon tells the liver to produce and release more sugar into the bloodstream (gluconeogenesis). In type 2 diabetes, this suppression is impaired, so the liver continues to release glucose even when blood glucose is already high.

Understanding this hormonal defect was the key that unlocked the development of GLP-1 receptor agonists—medications designed to mimic the action of our natural GLP-1 and restore these vital functions.

The Silent Threat: Hyperhomocysteinemia and its Impact on Your Health- Video

How GLP-1 Receptor Agonists Revolutionize Treatment

GLP-1 receptor agonists are a class of medications that bind to and activate GLP-1 receptors throughout the body, just as our native GLP-1 would, but they are engineered to last much longer. Their multifaceted mechanism of action addresses several core issues in type 2 diabetes and obesity simultaneously.

Stimulates Insulin Secretion: By activating pancreatic receptors, they prompt a glucose-dependent release of insulin, directly lowering blood sugar.
Inhibits Glucagon Secretion: They effectively tell the liver to stop producing excess sugar, which is a major contributor to high fasting and post-meal glucose levels.
Slows Gastric Emptying: This is a key mechanism for both glucose control and weight loss. By slowing down the rate at which food leaves the stomach, they prevent rapid spikes in blood sugar after meals. This delay also contributes to a prolonged feeling of fullness, which naturally leads to a decrease in overall food intake. This effect is often responsible for the common initial side effects like nausea, but it is also a primary driver of the medication’s success.
Increases Satiety: GLP-1 receptor agonists act directly on appetite centers in the brain, enhancing the feeling of fullness and reducing food cravings. This neurobiological effect is fundamental to the significant weight loss seen with these therapies.

Collectively, these actions lead to profound improvements in A1c, blood glucose, and body weight, tackling the metabolic dysfunction of type 2 diabetes at its source.

The Challenge of Over-Basalization: A Case Study

To truly understand the paradigm shift in diabetes care,let’ss consider a typical patient I might see in our clinic, whom we’ll call Tony. He represents a common challenge where adding a GLP-1 agonist is the superior strategy.

Patient Profile: Tony
Age: 62 years
Diagnosis: Type 2 Diabetes (11 years), Hyperlipidemia, Hypertension
Recent A1c: 8.2% (well above the target of <7.0%)
Kidney Health: Proteinuria (protein in the urine), an early sign of kidney damage.
Current Medications:
- Degludec (basal insulin): 65 units daily
- Metformin: 1000 mg twice daily
- An SGLT2 inhibitor daily
- A statin for cholesterol
An ARB for blood pressure
Physical Stats: Weight 220 lbs, Height 5’9 ” “, BMI 32.5 (classifies as obese)
Blood Sugar Patterns:
- Fasting Glucose (morning): 15050 mg/dL
- Postprandial Glucose (after meals/bedtime): 160-200 mg/dL

Tony’s case highlights a critical issue we call over-basalization. We’ve pushed his basal (long-acting) insulin dose to a high level, yet his A1c and post-meal sugars remain dangerously elevated. Research in pharmacokinetics reveals that once you exceed a certain dose of basal insulin, typically around 0.5 units per kilogram of body weight per day, you get diminishing returns. For Tony, who weighs 100 kg (220 lbs), this threshold is about 50 units. He is already on 65 units, pushing him past the point of modest glycemic effect and into the territory of significant side effects, primarily weight gain and a higher risk of hypoglycemia.
For a patient like Tony, the conventional next step might have been to add prandial (mealtime) insulin. While this can control post-meal spikes, it comes with a heavy price: a near-certainty of further weight gain and a significantly increased risk of hypoglycemia. Given his BMI of 32.5, adding more weight would only worsen his insulin resistance, creating a vicious cycle.
This is where the 2024 guidelines from the American Diabetes Association (ADA) strongly recommend adding a GLP-1 receptor agonist. It addresses multiple problems at once, moving beyond simple glucose lowering, weight loss, and cardiovascular protection, which are crucial for a high-risk patient like Tony.

Beyond Blood Sugar: The Cardiovascular and Renal Benefits of GLP-1s

Perhaps the most exciting development in the story of GLP-1 agonists is the overwhelming evidence of their protective effects on the heart and kidneys. Several landmark trials have established these powerful benefits:

The LEADER Trial (Liraglutide): This trial studied patients with type 2 diabetes and high cardiovascular risk. It showed a significant reduction in the risk of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack, and non-fatal stroke.
The SUSTAIN-6 and PIONEER 6 Trials (Semaglutide): Both the injectable (SUSTAIN-6) and oral (PIONEER 6) forms of semaglutide were studied in patients with high cardiovascular risk. Both trials demonstrated a robust reduction in MACE, confirming the class effect.
The REWIND Trial (Dulaglutide): What made this trial unique was its focus on a broader population, including many patients who had risk factors for cardiovascular disease but had not yet had an event. It demonstrated that dulaglutide can be used for primary prevention, reducing the risk of a first cardiovascular event.
Tirzepatide (Mounjaro®, Zepbound™): This is a newer, highly potent dual GIP/GLP-1 receptor agonist. While its final CVOTs are still pending as of June 15, 2026, preliminary data suggest powerful cardiovascular benefits are likely.

More recently, the FLOW trial for semaglutide was stopped early because of overwhelmingly positive results showing a significant reduction in the risk of kidney disease progression (nephropathy). These findings are game-changers, solidifying the role of GLP-1 agonists as essential therapies for patients with or at high risk for heart and kidney disease.

Navigating Side Effects and Safety Considerations of GLP-1 Agonists

As with any potent medication, GLP-1 agonists are not without side effects. As clinicians, our job is to help patients navigate these challenges.

Gastrointestinal (GI) Issues: Nausea, vomiting, and diarrhea are common and caused by delayed gastric emptying. My clinical advice is always to “start low and go slow,” beginning with the lowest dose and titrating upwards gradually.
Dehydration and Acute Kidney Injury (AKI): Patients on these medications must drink plenty of water to prevent dehydration due to GI side effects.
Gallbladder Disease: Rapid weight loss, regardless of the method, is associated with an increased risk of gallstone formation.
Pancreatitis: Recent large-scale studies as of early 2025 have been reassuring, finding no statistically significant increase in the risk of pancreatitis and even suggesting a potential long-term risk reduction by improving metabolic health.
Thyroid C-Cell Tumors: These medications carry a black box warning due to an increased risk of thyroid C-cell tumors in rodents. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Muscle and Bone Loss: This is a feature of significant weight loss in general, not something specific to these drugs. This is where our integrative care becomes critical.

An Integrative Chiropractic Perspective on Metabolic Health

As a Doctor of Chiropractic with advanced training in functional medicine, I view the body as an integrated system. When I see a patient, I don’t just see a person with diabetes and heart disease. I see a complex interplay of systemic inflammation, metabolic dysfunction, and biomechanical stress. This is where our unique approach at Injury Medical Clinic PA provides immense value. The side effects and physiological changes associated with modern diabetes therapies are whole-body issues we can address.
Here’s how integrative chiropractic care fits into this new paradigm:

Addressing Systemic Inflammation: Chronic inflammation is a root cause of both ASCVD and insulin resistance. Chiropractic adjustments have been shown to modulate the nervous system and can have a downstream effect on inflammatory pathways. By reducing spinal misalignments (subluxations), we can help normalize nerve function, which in turn influences the body’s inflammatory response.
Promoting Physical Activity and Combating Muscle Loss: Exercise is a critical component of managing diabetes. However, many patients are limited by musculoskeletal pain. As chiropractors, our primary role is to improve biomechanical function, reduce pain, and restore mobility. Furthermore, with the rapid weight loss induced by GLP-1s, there is a risk of sarcopenia (muscle loss). We implement targeted strength training and rehabilitation protocols to preserve and build lean muscle mass. By treating underlying musculoskeletal issues, we empower patients to engage in the physical activity necessary for their metabolic health.
Functional Medicine and Nutritional Counseling: My training as a Certified Functional Medicine Practitioner (CFMP) allows us to go deeper. We create personalized nutrition plans and recommend targeted supplementation to reduce inflammation, improve insulin sensitivity, and support cardiovascular health. To combat muscle loss, we ensure patients consume adequate protein to support muscle synthesis. This complements the work of medications by addressing the foundational lifestyle factors that drive disease.
Stress Management and Autonomic Balance: The autonomic nervous system plays a huge role in regulating blood pressure, heart rate, and metabolic function. Chronic stress leads to a state of sympathetic (“fight-or-flight”) dominance, which can worsen hypertension and insulin resistance. Chiropractic care, along with techniques like breathwork and meditation, helps promote a parasympathetic (“rest-and-digest”) state, supporting better cardiovascular and metabolic regulation.

In our clinic, a patient would receive a comprehensive plan. Under the medical direction of Dr. Cardenas, they might be started on an SGLT2 inhibitor or a GLP-1 agonist. Simultaneously, my team would work with them on a personalized plan including chiropractic adjustments to improve mobility, an anti-inflammatory diet, and a progressive exercise program they can perform without pain. This integrated approach addresses the disease from multiple angles, leading to far better and more sustainable outcomes. This is the future of chronic disease management—a holistic, patient-centered, and team-based model of care.

References

SEO Tags: SGLT2 inhibitors, GLP-1 receptor agonists, cardiovascular disease, type 2 diabetes, chronic kidney disease, heart failure, integrative chiropractic care, functional medicine, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso, TX, ASCVD, risk reduction, metabolic health, incretin effect, over-basalization, tirzepatide, semaglutide, Mounjaro, Ozempic, diabetes management, A1c reduction, weight loss and diabetes, nephroprotection, cardioprotection, collaborative care, internal medicine, chiropractic, personal injury care, musculoskeletal health

July 2, 2026

Peptide Therapy, Nutrition, and Integrative Chiropractic Care

A Whole-Body Approach to Healing in El Paso

Healing is not just about one treatment. The body repairs best when the spine moves well, the nervous system communicates clearly, inflammation is managed, and cells have the nutrients they need. This is why integrative care has become an important option for many people dealing with pain, injury, fatigue, inflammation, or slow recovery.

At ChiroMed – Integrated Medicine in El Paso, the focus is on whole-person care. This means the team looks beyond symptoms. They consider movement, posture, nutrition, inflammation, lifestyle habits, and the body’s natural healing systems. This type of care can be helpful for people recovering from auto accidents, work injuries, sports injuries, back pain, neck pain, sciatica, soft-tissue injuries, and other musculoskeletal problems (ChiroMed, n.d.-a).

Peptide therapy can fit into this type of care when it is used carefully and under proper medical guidance. Peptides are short chains of amino acids. Amino acids are the building blocks of protein. In the body, peptides can act like tiny messengers that help cells communicate. Some peptides help regulate metabolism. Others may support tissue repair, inflammation balance, immune function, or recovery (Holistiq, 2026; Parker Chiropractic & Acupuncture, n.d.).

But peptides are not magic. They are not a cure-all. They work best when paired with the basics: chiropractic care, nutrition, rehabilitation, sleep, hydration, medical oversight, and healthy daily habits.

What Are Peptides?

Peptides are small chains of amino acids. They are naturally found in the body and help guide many important functions. Some act like hormones. Some help with cell repair. Some help regulate appetite, inflammation, or immune response (Holistiq, 2026).

A simple way to understand peptides is to think of them as messages sent to cells. A peptide may tell the body to:

Support tissue repair
Reduce inflammatory stress
Help regulate metabolism
Improve recovery after physical strain
Support gut and immune balance
Help maintain lean muscle during weight-loss care

This is why peptide therapy is often discussed in functional medicine, regenerative medicine, chiropractic care, sports recovery, and metabolic health (ProCredits, 2025).

However, not all peptides are the same. Some have strong medical uses. Others have limited human research. Some are regulated differently depending on how they are made, prescribed, or compounded. For this reason, peptide therapy should be considered only under qualified medical oversight and with a clear care plan (U.S. Food and Drug Administration, 2026).

Why Nutrition Matters During Peptide Therapy

Peptides may send the message, but nutrition supplies the materials.

For example, a tissue-repair peptide may help signal the body to repair a ligament, tendon, muscle, or joint capsule. But if the person does not eat enough protein, the body may not have the amino acids needed to complete that repair. The message is there, but the building blocks are missing.

This is why nutrition and peptide therapy should work together. A strong nutrition plan can provide the body with:

Amino acids from protein
Vitamins that support tissue repair
Minerals that help cells function
Healthy fats for hormones and cell membranes
Antioxidants from fruits and vegetables
Hydration for circulation and recovery

Med Matrix USA explains that nutrition and peptides can support each other, as the body needs adequate nutrients to respond to cellular signals (Med Matrix USA, 2026). Clean Eatz also notes that people using peptide-based weight-loss or recovery plans need enough protein to protect muscle and support metabolism (Clean Eatz, 2026).

Protein: The Body’s Repair Supply

Protein is one of the most important parts of a healing plan. Since peptides are made from amino acids, the body needs protein to repair and rebuild tissue.

Good protein choices may include:

Eggs
Chicken
Turkey
Fish
Lean beef
Greek yogurt
Cottage cheese
Beans
Lentils
Protein shakes when appropriate

Protein can support muscle recovery, ligament healing, tendon repair, immune function, and healthy metabolism. It is especially important for people recovering from injury, training hard, or using weight-loss medications that lower appetite.

When a person eats too little protein, healing may slow down. Muscle loss may also become a concern. This is why peptide care should not be separated from a nutrition plan.

Chiropractic Care and the Nervous System

Chiropractic care focuses on the spine, joints, muscles, and nervous system. The nervous system helps control movement, pain, digestion, inflammation response, and healing. When joints are stiff, muscles are guarded, or the spine is not moving well, the body may remain in a state of stress.

Chiropractic adjustments can help improve joint motion and reduce mechanical stress. Rehabilitation can help retrain the body to move with better strength, balance, and control. Nutrition can support the body from the inside. Peptides, when appropriate, may help support cellular signaling.

Together, these tools can create a stronger healing environment.

At ChiroMed, this type of care is especially important for patients with injuries. Many injuries involve more than one tissue. A car accident, for example, may affect the spine, muscles, ligaments, nerves, posture, sleep, stress levels, and daily movement. A complete plan should look at all of these areas.

How Peptides May Support Injury Recovery

Peptide therapy is often discussed as a support option for tissue repair, inflammation balance, metabolic health, and recovery. Some integrative and chiropractic sources describe peptides as helpful tools that may support muscles, tendons, ligaments, joints, and overall healing response (Back to Wellness Chiropractic, 2026; Spectrum Pain Management, 2024).

In an injury-focused setting, peptide therapy may be considered for patients dealing with:

Soft-tissue strain
Ligament stress
Tendon irritation
Joint discomfort
Slow recovery after injury
Metabolic issues that may slow healing
Inflammation that does not calm easily
Muscle loss during weight-loss care

Meeting Point Health describes peptide therapy as a regenerative support option that may be used alongside other orthopedic and functional medicine strategies (Meeting Point Health, 2024).

Still, patients should understand that healing takes time. Peptides do not replace diagnosis, imaging, chiropractic care, physical rehabilitation, medical care, nutrition, or lifestyle changes. They may support the process, but they do not replace the foundation.

The ChiroMed Model: Integrated Care Under One Roof

ChiroMed’s care model is built around integrated medicine. This means different clinical tools are used together to support the patient’s recovery. The clinic’s services include chiropractic care, nurse practitioner care, nutrition, rehabilitation, naturopathic medicine, and related services (ChiroMed, n.d.-b).

This type of setup is valuable because pain and poor recovery often have multiple causes. A patient may have a spinal restriction, but also poor nutrition. Another patient may have inflammation, muscle weakness, and stress-related sleep problems. Another may have an injury case that needs clear documentation, function testing, and consistent follow-up.

An integrated care model may include:

Chiropractic adjustments
Functional medicine review
Nutrition support
Rehabilitation exercises
Soft-tissue care
Injury documentation
Medical oversight
Lifestyle coaching
Appropriate referrals when needed

This gives the patient a more complete plan instead of a one-size-fits-all approach.

Dr. Alex Jimenez and Dr. Maria Cardenas: A Collaborative Clinical Team

At ChiroMed and Injury Medical Clinic PA in El Paso, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, brings a dual-scope clinical background as both a chiropractor and board-certified family nurse practitioner. His clinical observations often focus on the connection between spine health, functional medicine, inflammation, nutrition, injury recovery, and rehabilitation (Jimenez, n.d.-a; Jimenez, n.d.-b).

Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA. Her listed credentials include NPI #1164426749 and Texas MD License #J2933. She brings more than 40 years of experience as an internist, adding medical direction and internal medicine insight to the clinic’s multidisciplinary model (ChiroMed, n.d.-c; Healthgrades, n.d.).

This setup is common in integrative and injury care clinics. The chiropractor helps evaluate and treat problems with the spine, joints, posture, and movement. The medical doctor provides medical oversight, internal medicine perspective, and collaborative direction. The care team can then support patients through chiropractic care, personal injury care, functional medicine, nutrition, rehabilitation, and related services.

Why Medical Oversight Is Important With Peptides

Peptide therapy should be handled carefully. Some peptides have FDA-approved medical uses. Others may not be FDA-approved for common wellness or injury claims. The FDA has also warned that certain compounded peptide products may raise concerns about impurities, immune reactions, and limited human safety data (U.S. Food and Drug Administration, 2026).

This does not mean every peptide is unsafe. It means peptide therapy should be thoughtful, legal, and medically guided.

Responsible peptide care may include:

A full health history
Medication review
Review of medical conditions
Lab testing when appropriate
Clear treatment goals
Follow-up visits
Proper sourcing
Safety monitoring
A nutrition and lifestyle plan

Patients should avoid buying peptides from unknown online sources. Products sold without proper medical oversight may be mislabeled, contaminated, or used incorrectly.

A Simple Example of Integrated Healing

Imagine a patient with low back pain after a car accident. The patient has tight muscles, poor sleep, inflammation, low protein intake, and reduced movement. A simple pain-relief-only plan may miss the bigger picture.

At an integrated clinic like ChiroMed, the care plan may include:

Chiropractic evaluation
Range-of-motion testing
Soft-tissue treatment
Rehabilitation exercises
Nutrition guidance
Medical oversight
Injury documentation
Peptide discussion only if appropriate

In this case, chiropractic care may help restore movement. Rehab may rebuild strength. Nutrition may give the body the materials it needs to repair. Medical oversight may improve safety. Peptides may support cellular messaging if they fit the patient’s needs.

The goal is not to chase symptoms. The goal is to help the body recover with structure, support, and a clear plan.

Peptides Are a Catalyst, Not the Whole Plan

Peptides may help support healing signals, but they are only one part of care. A strong recovery plan still depends on the basics.

The foundation should include:

Proper diagnosis
Chiropractic care when appropriate
Targeted rehabilitation
Adequate protein
Anti-inflammatory nutrition
Hydration
Sleep support
Stress management
Safe medical oversight

Elevated Integrative Wellness explains that peptides work best when combined with lifestyle habits such as nutrition, exercise, sleep, and stress control (Elevated Integrative Wellness, n.d.).

That message fits well with ChiroMed’s whole-person approach. Healing is not just about what is injected, adjusted, or prescribed. Healing also depends on what the patient eats, how they move, how they sleep, and how well the nervous system and metabolism are supported.

Final Thoughts: Building a Better Healing Environment

Peptide therapy can be a useful tool when it is used wisely. It may support tissue repair, recovery, inflammation balance, metabolism, and whole-body function. But it should not be treated like a shortcut.

The body needs signals, structure, and supplies.

Peptides may provide signals. Chiropractic care may improve structure and movement. Nutrition provides the supplies. Rehabilitation teaches the body how to move again. Medical oversight helps keep the plan safe and appropriate.

At ChiroMed – Integrated Medicine, the goal is to support recovery through a multidisciplinary model. With Dr. Alex Jimenez, DC, APRN, FNP-BC, leading chiropractic, functional medicine, injury, and rehabilitation care, and Dr. Maria Guadalupe Cardenas, MD, serving as Medical Director and Collaborative Physician, patients have access to a team-based approach that looks at the whole person.

For people in El Paso dealing with injury, pain, inflammation, or slow recovery, this type of integrative care can help create a better environment for healing from the inside out.

References

Back to Wellness Chiropractic. (2026). Peptide therapy: A key to enhanced wellness in Parker, Colorado.

ChiroMed. (n.d.-a). ChiroMed – Integrated Medicine: Holistic healthcare in El Paso, TX.

ChiroMed. (n.d.-b). Integrated medicine services El Paso TX.

ChiroMed. (n.d.-c). Contact us.

Clean Eatz. (2026). This is peptide nutrition 101.

Creekside Wellness. (n.d.). Peptide therapy.

Elevated Integrative Wellness. (n.d.). Peptide therapy.

Healthgrades. (n.d.). Dr. Maria Cardenas, MD: Internist in El Paso, TX.

Holistiq. (2026). What are peptides?.

Integrative Health & Wellness. (n.d.). Peptide therapy.

Integrative Wellness IV. (n.d.). Peptides.

Jimenez, A. (n.d.-a). El Paso, TX chiropractor Dr. Alex Jimenez DC.

Jimenez, A. (n.d.-b). Dr. Alexander Jimenez DC, APRN, FNP-BC, IFMCP, CFMP, ATN.

Meeting Point Health. (2024). Peptide therapy for injury repair: Faster healing with regenerative orthopedic support.

Med Matrix USA. (2026). Nutrition and peptide therapy: How they work together.

Parker Chiropractic & Acupuncture. (n.d.). Peptide therapy.

Pfister Functional Medicine & Chiropractic. (n.d.). Peptides.

ProCredits. (2025). Peptide therapy for chiropractors: Tissue repair and metabolic health.

Spectrum Pain Management. (2024). Unlocking the power of peptides in pain management: A chiropractic perspective.

Total Health Solutions. (n.d.). Total Health Solutions.

U.S. Food and Drug Administration. (2026). Certain bulk drug substances for use in compounding may present significant safety risks.

Category: Advanced Practice Registered Nurses (APRN)

Abstract: A Modern, Integrative Approach to Obesity Management

Our Collaborative and Integrative Care Model in El Paso

Deconstructing Obesity: A Chronic and Complex Disease

The Social and Environmental Drivers of Obesity

The Overwhelming Complexity of Appetite Regulation

Binge Eating Disorder and the Physiology of Loss of Control Eating

Confronting Weight Bias: The Last Socially Acceptable Discrimination

Shifting the Conversation: How to Engage Patients Effectively

A Framework for Treatment: Lifestyle, Medication, and Surgery

Why “First, Do No Harm” Matters in Obesity Treatment

Modern Pharmacotherapy for Weight Management

Emerging Obesity Medications and Future Directions

Discovering the Benefits of Chiropractic Care- Video

The Role of Integrative Chiropractic Care in Weight Management

Final Clinical Takeaway

References

Building a Better Environment for Recovery

The “Seed and Soil” Model of Healing

How Platelet-Rich Plasma May Support Healing

Understanding PFP Therapy

How MFAT May Support Joint Recovery

Epidural Spinal Injections for Nerve Pain

The Role of IV Infusion Nutrient Therapy

Chiropractic Care Helps Prepare the Body

Returning to Exercise Safely

Stage 1: Protect and Calm the Area

Stage 2: Restore Movement

Stage 3: Rebuild Strength

Stage 4: Return to Fitness

Multidisciplinary Care at ChiroMed

A Complete Approach to Wellness and Fitness

References

Why Accident and Work Injuries Need a Complete Plan

Phase One: Identify the Injury and Reduce Inflammation

Phase Two: Restore Spinal and Joint Mechanics

Chiropractic Care

Spinal Decompression

Phase Three: Address Stubborn Soft-Tissue Injuries

Platelet-Rich Plasma Therapy

Microfragmented Adipose Tissue

Laser and Shockwave Therapy

Therapeutic Laser

Shockwave Therapy

Phase Four: Support Healing Through Nutrition

IV Nutrient Support

Phase Five: Rebuild Strength and Function

Team-Based Injury Care at ChiroMed

A Clearer Path From Injury to Recovery

References

Abstract

Our Collaborative Approach at Injury Medical Clinic PA

The Unseen Connection: How Diabetes Fuels Heart Failure

Understanding the Two Faces of Heart Failure

Heart Failure with Preserved Ejection Fraction (HFpEF)

Heart Failure with Reduced Ejection Fraction (HFrEF)

Optimizing Your Wellness- Video

The Four Pillars of Modern Diabetes and Cardiovascular Care

The Revolutionary Role of SGLT2 Inhibitors

Landmark Trials: The Evidence Speaks for Itself

How SGLT2 Inhibitors Protect the Heart and Kidneys

GLP-1 Receptor Agonists From Diabetes Drugs to Cardiovascular Powerhouses

How GLP-1 Receptor Agonists Work

The FDA-Mandated Outcomes Trials: A Turning Point

The ADA Algorithm Drug Selection Framework

A Clinical Case Example Transitioning Patients to Modern Therapy

The Integrative Chiropractic and Functional Medicine Perspective

How Our Integrative Care Fits In

References

Helping Athletes Recover at the Mechanical and Cellular Levels

Why Sports Injuries Need a Complete Evaluation

Chiropractic Care Restores Mechanical Movement

Spinal Decompression May Reduce Pressure

Shockwave Therapy Stimulates Stubborn Tissues

MLS Laser Therapy Supports Cellular Activity

What About Peptide Therapy?

A Multidisciplinary Team at ChiroMed

From Symptom Control to Active Recovery

The ChiroMed Approach to Sports Injury Recovery

References

Cardiometabolic Risk Causes & Effects- Video